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ABSTRACT
OBJECTIVE:
Prediction of successful vaginal delivery by measuring transvaginal
cervical length before induction.
STUDY DESIGN:
It  is  a  prospective  observational  study  done  in  250  women  with
gestational age ranging from 37-42 weeks of gestation. Cervical length is
measured before induction by trans-vaginal ultrasound. Both primi and
multigravida are included in our study. Induction with PGE2 gel is done.
RESULTS
Results are analyzed with ROC curve, the cut-off value predicting
successful vaginal delivery is 2.6cm with sensitivity of 97.4% and
specificity of 97.8% within 72 hours of induction. Area under curve is
0.975.
CONCLUSION
Thus trans-vaginal cervical length measured before induction can
be used to predict successful vaginal delivery.  In future, the traditional
method of assessing the favorability of cervix can be replaced by trans-
vaginal cervical measurement and add yet another dimension in field of
obstetrics.
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1INTRODUCTION
Incidence of labour induction is 22.5% (Martin and associates) 1.
The commonest indication is prolonged pregnancy2. Numerous studies
have shown that compared to expectant management induction is
associated with reduction in perinatal mortality.
The prediction of successful vaginal delivery is based on
favourability of cervix before induction and it’s determined by Bishop’s
score3-5. But this assessment is subjective and studies have proved to have
poor predictive value for induction outcome in women with low Bishop’s
score6.
The use of trans-vaginal ultrasound has increasing application in
the field of induction of labour in obstetrics. Trans-vaginal cervical length
measurement used mainly to detect changes in cervix of women with risk
of preterm delivery.
Theoretically trans-vaginal sonographic measurement of the cervix
represents more accurate assessment of cervix than digital examination7.
Here the supravaginal portion of cervix contributing to 50% of the total
cervical length is difficult to assess digitally and also the assessment of
the effacement which begins at the level of internal os is difficult to
predict in closed cervix.
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2But sonographic measurement of the cervical length is easily
reproducible method and it can be done easily with minimal discomfort to
patient. This study was undertaken in the institute of ESIPGIMSR to
determine the successful labour induction by measuring trans-vaginal
cervical length.
Further trans-vaginal cervical length measurement in future can be
used as an adjunct tool and add yet another dimension of information in
the field of obstetrics.
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3AIM OF THE STUDY
Prediction of successful vaginal delivery by measuring trans –
vaginal cervical length before induction.
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4REVIEW OF LITERATURE
(A) HISTORIC PROSPECTIVES OF PREDICTION OF
SUCCESSFUL LABOUR INDUCTION BY PREINDUCTION
SCORING
? Among the different cervical scoring systems described Bishop’s
scoring system (1964) is most commonly used.
? FFN (Foetal Fibronectin) concentrations are measured in the
cervico-vaginal secretions. If <50 mcg/ml its favourable cervix and
more chance of successful labour induction (Ekman et al., 1995).
Shorter induction delivery interval with positive FFN than negative
FFN. (Kiss et al 2000).
? Trans-vaginal cervical length measurement has been investigated
as tool for prediction of outcome of induced labour and as an
alternative to traditional Bishop’s scoring system. Several studies
have determined the relationship between cervical length, internal
os changes and angle between cervical axis and inferior segment of
uterus. (Chandra et al 2001)
? Electrical impedance measurements is done with 8 mm tetra polar
pencil probe over surface of cervix to determine correlation of
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5cervix favourability  with clinical examination.( O’Connell et al.
2003)8
? Serum nitrate/ nitrite levels: These levels are lower in nulliparous
women undergoing induction of labour with prostaglandins. Serum
nitrate/nitrite levels are lower in women who delivered within 15
minutes than those who are not delivered.
(B) HISTORIC PROSPECTIVES OF PROSTAGLANDINS AND
ITS ROLE IN INITIATION OF LABOUR
Kurzrok and Leib in 1930 noted the presence of prostaglandins in
human semen and its ability to initiate uterine contractions. Von Euler
named it as prostaglandins after isolating it from male prostate gland.
(Von EULER 1936). He thought it was unique secretion from prostate
gland. Later it was found that prostaglandins are large family of
substances ubiquitous in mammalian biology. (Collin 1990; Calder 1997).
There are six groups of Prostaglandins from Ato F.
? Prostaglandins E and F have been demonstrated in amniotic fluid
of term women  after rupture of membranes and it makes the
pregnant uterus to contract. (Karim 1966) but amniotic fluid
obtained from early gestation causes relaxant effect. (Karim 1967).
The amniotic fluid concentration of prostaglandins increase with
onset of labour. (Kierse 1973, Hibbard 1974) and with increasing
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6cervical dilatation. (Kierse 1973, 1974, 1977). Levels are lower in
poor progression of cervical dilatation. (Kierse 1977, Reddy 1987).
Prostaglandins are detected in umbilical cord, amnion, chorion, and
placenta decidual and myometrial tissue with greater
concentrations of PGE2 than PGF2alpha. (Williams 1976 B).
There must be interaction of prostaglandin with the receptors
specific to it for biological action. These receptors are present in
significant numbers in both pregnant and non-pregnant uterus and
they are sensitive to prostaglandin stimulation throughout
pregnancy. (O’Brein 1995). In contrast oxytocin receptor
concentration increases as pregnancy advances. (Fuchs 1984,
O’Brein 1995).
Pre-induction sonographic measurement of cervical length in
prediction of successful induction of labour.9 Pandis et al done a study to
determine the relationship between pre-induction sonographic
measurement of cervical length and Bishop score and they compared the
two measurements in the prediction of vaginal delivery within 24 hours.
240 women are taken for this study.   Bishop score was determined by
digital examination and cervical length was measured by trans-vaginal
ultrasound. Multiple regression analysis showed that cervical length,
Bishop Score and parity are independent predictors of the vaginal
delivery within 24 h. In receiver operating characteristic curves, the cut-
off point for prediction of successful vaginal delivery after induction was
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728 mm for cervical length and 3 for Bishop Score. But, cervical length
was a better predictor than the Bishop score, with sensitivity of 0.87 and
specificity of 0.71 compared to 0.58 and 0.77, respectively. They
concluded that trans-vaginal sonographic measurement of cervical length
provides a better prediction of vaginal delivery within 24 hours of
induction than Bishop’s score.
Trans-vaginal Ultrasound for Cervical Assessment before
Induction of Labour.10 Soon Ha Yang et al done a study to evaluate the
Trans vaginal ultrasonographic cervical assessment in prediction of
outcome of labour induction and to compare it against the Bishop score.
Bishop Score was assessed by digital examination, and trans-vaginal
ultrasonography was performed in 105 women. Cervical length, presence
of funnelling, funnel width, and funnel length are noted. The primary
outcome was the active labour within 48 hours (successful labour
induction).  Secondary outcome was duration of outcome. Statistical
analysis was performed .Induction of labour was successful in 89%. The
area under receiver operating characteristic curve for cervical length was
greater than Bishop Score in prediction of successful labour induction (z
= 2.18; P < .05). Cervical length of <3.0 cm had sensitivity of 75% and
specificity of 83%. Multiple logistic regression analysis demonstrated
significant relationship between successful labour induction and cervical
length but not Bishop Score (odds ratio = 0.24; 95% confidence interval,
0.096–0.59; P = .002).  They concluded that cervical length measured by
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8trans-vaginal ultrasound is a useful and independent predictor of
successful labour induction.
Sonographic assessment of the cervical length before induction of
labor.11 Ibrahim et al studied 120 women who underwent labour
induction after determination of Bishop’s score and trans-vaginal cervical
length measurement.  Results showed that trans-vaginal cervical length is
shorter in women those who delivered vaginally (24.7+/-6.9) compared to
those who delivered by caesarean section (26.5+/-8.2).78.3% delivered
vaginally and 10 %( 35.7%) delivered by caesarean section.  Thus the
conclusion was that both trans-vaginal cervical length and the Bishop’s
score are significantly associated with successful induction.
Rane et  al12 examined the effect of pre-induction cervical length,
gestational age at induction, parity, body mass index (BMI)  and maternal
age on the possibility of successful vaginal delivery in women
undergoing induction. Induction of labour was done in 822 singleton
pregnancies and cervical length was measured by trans-vaginal
sonography before induction.  Cox's proportional hazard model was used
for analysis. Successful vaginal delivery within 24 hours of induction in
64.5% and Caesarean sections 19.6% and they concluded that women
undergoing induction of labour, pre-induction cervical length, gestational
age at induction, parity, BMI and maternal age have significant effect on
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9the interval between induction and delivery within 24 hours, and the risk
of caesarean section.
Maitra et al13 a total of 100 women were studied to determine the
trans-vaginal measurement of cervical length in  predicting  successful
vaginal delivery within 24 hrs. Induction  was carried out with Tab
Misoprostol (25 micro gram).  Bishop's score and sonographic cervical
assessment was done prior to induction. Univariate and logistic regression
analyses were used.  At < or =3 cm cervical length, the rate of LSCS was
<30%, while 4cm cervical length, the probability becomes >75%. Thus
cervical length measurement by TVS is an independent predictor of
successful labour induction and its better than Bishop's score as a method
of pre-induction cervical assessment.
Keepanasseril et al14 compared the ultrasonographic cervical
assessment with Bishop score before induction in prediction of successful
labour  induction. This was a prospective study in 138 women. Cervical
length, posterior cervical angle and funnelling are noted. Labour
induction was successful in 106 (76.8%).The best cut-off point in receiver
operating characteristics curve was 3.0 cm for cervical length had
sensitivity of 84.9%, and a specificity 90.6%.of and 100 degrees for
posterior cervical angle. Cervical length of 3.0 cm had a 90.6% and a
posterior cervical angle of 100 degrees with 65% and 72%, respectively.
They concluded that trans-vaginal sonographic assessment of cervical
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10
length and posterior cervical angle is better than conventional Bishop
Score in predicting successful labour induction in nulliparous women.
Pre-induction cervical length measurement in prolonged pregnancy
(Nicolaides et al)15 to determine the effect of parity on the  pre-induction
cervical length and the induction-to-delivery interval and successful
vaginal delivery within 24hrs in women with prolonged pregnancy. In
382 singleton pregnancies, induction of labour was done. Univariate
analysis showed cervical length and parity provide independent predictors
of vaginal delivery and induction-to-delivery interval.
Parvin et al16 aim  of  study  was  to  compare  Bishop’s  score  and
trans-vaginal cervical length measurement in prediction of caesarean
section after induction.200 women participated in this study. The Area
under Curve (AUC)  for cervical length by ultrasonography was 0.69
(95% CI 0.6-0.77) and AUC for the posterior cervical angle was 0.38
(95% CI 0.29-0.47). ROC for cervical length is statistically different from
both Bishop score and posterior cervical angle (P < 0.001).Cervical
length measured by trans-vaginal ultrasonography has the potential to
replace the Bishop score, provided the facility is available.
Trans-vaginal cervical length and BMI Predicts successful labour
induction than Bishop’s score.189 women participated in this study.BMI,
trans-vaginal cervical length and Bishop’s score are determined. Logistic
regression analysis showed that cervical length and BMI were
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11
independent predictors in determining the risk of caesarean section. ROC
curve also showed that the cervical length and BMI are best parameters in
predicting the risk of caesarean section compared to the Bishop score (the
areas under the curve (AUC) are 0.819, 0.701 and 0.416, respectively).
Assessment of tolerability and prediction of caesarean delivery
(Tan et al) 17 prospective study was performed on 249 women.  Cervical
length was measured with trans-vaginal ultrasound. A 10-point visual
analogue scale (VAS) for pain was obtained for Bishop’s score and trans-
vaginal cervical length.  Trans-vaginal sonography was less painful than
digital examination for Bishop Score (mean difference in VAS score
3.46; P<0.001). P=0.015, respectively) and optimal cut-off points for
predicting caesarean delivery is Bishop score<or=5 and Cervical length
of >20mm. Trans-vaginal sonographic measurement is better tolerated
than digital examination. Cervical length>20 mm at term before labour
induction is an independent predictor of Caesarean delivery.
Trans-vaginal sonographic cervical assessment as a predictor of
successful labour induction.18Trans-vaginal scan is done to determine
cervical length and cervical gland area in 80 pregnant women. Bishop
score and pre-induction serum prostaglandin E2 metabolite were
determined by ELISA technique.  Women with cervical length <3.0 cm
and higher PGE2 levels had shorter labours (P< 0.01) .The PGE2 level
was significantly higher in multiparous than nulliparous women (P <
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12
0.01). Cervical measurement, parity and serum PGE2 were independent
predictors of the mode of delivery.
Cervical length and volume in prediction of onset of labour.19The
cervical length was longer and cervical volume was larger in women who
delivered 7 days or more than those who delivered within 7 days of
measurement in VBAC patients. The ROC curve for cervical length is
more predictive than cervical volume (AUC: 0.711 vs. 0.594, p= 0.001).
To determine the accuracy of trans-vaginal cervical length and
funnelling in predicting spontaneous onset of labour20. 150 women
included in study and observed for onset of labour for 7 days and that
they are significant predictors.
Trans-vaginal cervical length measurement in prediction of labour
induction.21Raynor showed that Cervical length <3 cm and Bishop’s
score >4 had shorter labour. Logistic regression analysis showed that
cervical length and parity are independent predictors of vaginal delivery.
To determine the effect of cervical length, parity on induction
delivery interval and vaginal delivery within 24 hours22. Successful
vaginal delivery occurred in 67% of women. In multipara the vaginal
delivery was 30% higher than nulliparous with same cervical length.
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
13
Pre-induction cervical ripening with intracervical and intravaginal
PGE2 gel23. In both these groups there is no difference in spontaneous vs
induced labour, need for augmentation, induction delivery interval.
Glutaredoxin levels are increased in human cervix after
prostaglandin treatment. These levels are 3 times higher in prostaglandin
E2 treated women and plays an important role in cervical ripening.24
Comparison of quantitative elastography of cervix, Bishop’s score,
Ultrasound cervical length in prediction of successful labour induction.
The cervical tissue strain was measured using tissue Doppler imaging by
compressing the cervix in longitudinal axis. The functional cervical
length provided better performance than Bishop’s score and elastography
of cervix.25
Ultrasound beats Bishop’s score in prediction of labour induction.
Cervical length measured trans-vaginally is a better predictor of vaginal
delivery within 60 hours of labour induction than traditional digital
examination.26
Intra-cervical application of PGE2 gel for induction of labour at
term.50 patients with unfavourable cervix given 0.5 mg of PGE2 gel into
cervical canal. There is a significant improvement of cervical score in
women given PGE2 gel and no improvement in placebo group.27
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Intra-cervical application of PGE2 gel for cervical ripening in
unfavourable cervix in IUGR patients. 80 women with ultrasound
diagnosis of IUGR(less than -2 SD)  induction done and concluded PGE2
gel is safe method of cervical ripening in women with IUGR.28
PGE2 gel for priming and labour induction at term patients with
unfavourable cervix. 50 women with unfavourable cervix induced with
PGE2 gel. Normal deliveries are 96% and 4% of caesarean section.29
Cervical priming by multiple doses of intra-cervical PGE2 gel.172
women were induced with cerviprime. Multiple doses were required in
24.4%,2 doses in 18% cases, 3 doses in 6.4% cases to significantly alter
Bishop’s score.30
Intra-cervical PGE2 gel for cervical ripening in unfavourable
cervix.50 patients at term induced with PGE2 gel. Success rate was 82 %(
vaginal deliveries) and caesarean rate was 18%. Thus they proved that
intra-cervical PGE2 gel is effective and safe method in term patients with
unfavourable cervix.31
Induction of labour with PGE2 gel can be done in women with one
previous LSCS. In 46 women induction was done and vaginal delivery
was 65.21% in study group and 79% in control group.32
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Evaluation of safety and efficacy of PGE2 gel in pre-labour rupture
of membranes. The total labour duration , latent phase, rate of caesarean
section were less compared to controls.33
PGE2 gel in ripening cervix. 75 patients were induced in unripe
cervix. Mean duration of latent phase-10.34hrs. Induction delivery time-
16.43 hrs. Vaginal delivery was 81.33% and LSCS was17.33%.
Commonest indication for LSCS was foetal distress34.
Dinoprostone to induce labour: To determine safety and efficacy of
intra cervical dinoprostone in prolonged pregnancy. In the study group 16
primiparous women and 21 multiparous women required only one dose.5
primiparous women and 3 multiparous women required 2 doses. They
concluded that intra-cervical gel is safe and acceptable method for labour
induction of labour induction in both primi and multigravida35.
Mika Nuutila et al conducted study in women with pre-eclampsia
with intra cervical PGE2 gel. 62.6% of women in the study group entered
into active phase of labour and augmented by oxytocin. Thus PGE2 gel is
effective and safe method for cervical ripening36.
Assessment of PGE2 gel in induction of labour induction: Prepedil
is efficient in labour induction compared to artificial rupture of
membranes with syntocin acceleration37.
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ANATOMY OF CERVIX 38
The cervix is fusiform in shape and open at each end by small
apertures called the internal and external os. The cervix is 5 cm in length
and upper segment of cervix is portiosupravaginalis and lower vaginal
portion of cervix is portiovaginalis. The ureter runs close to cervix 1.2 cm
away from portiosupravaginalis. Before child birth the external os is
small regular and circular opening but in multiparous women this orifice
is converted in to transverse slit with anterior and posterior lips of cervix.
PHYSIOLOGY
The cervix is complex organ that undergoes changes throughout
pregnancy and parturition39.The cervix has unique construction to retain
foetus till end of pregnancy and deliver safely during labour.The cervix
contains predominantly fibrous connective tissue made up of extracellular
matrix and smaller amount of cellular portion with smooth muscles,
fibroblasts, epithelium and blood vessels (Ludmir and Sehdev).
Extracellular matrix is made up of type 1 (70 %) and type 3 (30%)
collagen40.  These  collagens  are  arranged  in  the  form  of  triple  helix.  In
addition extracellular matrix contains glycosaminoglycans, proteoglycans
and elastin. Collagen fibres should crosslink to form long fibrils and
maintain  tensile  strength.   This  is  by  the  action  of  the  enzyme  peptidyl
lysine oxidase. Cofactors are copper and vitamin c.
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CERVICAL RIPENING
It starts in first trimester and continues till end of pregnancy and
described as softening, effacement and dilatation of cervix. Among these
softening is an important process because effacement and dilatation
cannot occur without softening. Softening occurs without contractions but
effacement and dilatation cannot occur without contractions.
SOFTENING of cervix occurs due to increased vascularity,
stromal and glandular hypertrophy with changes in extracellular
matrix.41The cervix is rigid throughout gestation because, dermaton
sulphate binds to collagen. The  concentration of dermaton sulphate and
progesterone  decreases in term and initiates inflammatory cascade and
releases matrix metalloproteins causing collagen degradation.42Collagen
fibrils interact with decorin or biglycan  and thrombospondin-2.They bind
together and form collagen fibrils of same diameter and packed in a
regular and highly organized pattern. During ripening of cervix there is
increased spacing between fibrils and hence there is disorganisation of
collagen fibrils. In ultra-structure analysis by electron microscopy of rat
cervix suggested that collagen dispersion predominates in ripening rather
than degradation (Yu and colleagues, 1995). Decorin is the small
molecular weight proteoglycan produced by cervical cells during
pregnancy.43 The ratio of decorin to collagen increases and hence
dispersal of collagen fibrils occurs. The disorganisation of cervix allows
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influx of water and makes cervix to distend. Further collagen is degraded
by the enzyme collagenases both intracellularly and extracellularly to
weaken collagen and this favours cervical ripening.
The cervical changes are induced by oestrogen, progesterone,
relaxin, cytokines, prostaglandin and nitric oxide synthesis enzymes.44
Nervous system also contributes to process of cervical ripening.
Sensory fibres from L6 to S1 terminate in cervix and synthesize
neurotransmitters (vasoactive neuropeptide, substance Calcitonin gene
related peptide) and induce cervical softening.45
MEASUREMENT OF CERVICAL SOFTENING
COLLASCOPE is used for quantitative estimation of cervical
ripening. It uses light induced fluorescence of the cross linked collagen to
allow obstetrician to distinguish between labour and non-labour state of
cervix.
FLUORESCENCE SPECTROSCOPY OF COLLAGEN: It
provides information of structure and dynamics of macromolecules
(collagen) and its location at microscopic levels.46
CERVICAL LIGHT INDUCED FLUORESCENCE (LIF):
Study on cervical collagen was done to know about changes of cervical
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LIF in pregnancy. These values are obtained noninvasively with
collascope.47
Women who delivered within 24 hours of measurement had lower
LIF compared to those delivered 24 hours later.
VARIOUS METHODS OF LABOUR INDUCTION
? NON PHARMACOLOGIC CERVICAL RIPENING
1. Herbal supplements-They are black haw, evening primerose oil,
red raspberry leaves, black and blue cohosh.They enhance uterine
contractions but their role in cervical ripening is uncertain48
2. Castor oil, Hot baths and Enemas- there is no evidence to support
that they cause cervical ripening49
3. Sexual intercourse- is recommended for labour initiation.
Stimulation of breast and nipple release oxytocin. Lower uterine segment
is stimulated by penetration.49
4. Breast stimulation: It releases oxytocin and induces labour.
Massaging of breasts with hot compresses three times a day causes
oxytocin release and foetal heart rate abnormalities similar to oxytocin
challenge test49.
5. Acupuncture / transcutaneous nerve stimulation:  Here fine needles
are inserted that stimulates  channels of energy and they are directed to
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specific organ but effectiveness is limited for labour
induction.Transcutaneous nerve stimulation causes release of
prostaglandins and oxytocin50.
MECHANICAL METHOD
They cause local pressure and releases prostaglandin.Risks are
endometritis and neonatal sepsis , membrane rupture, bleeding and
placental disruption.  Hygroscopic dilators  absorb endocervical fluid and
device expands and causes mechanical pressure. Natural is Laminaria
japonicum and synthetic is lamicel. Ballon devices(26 Fr Foley catheter )
is placed in cervix and balloon is filled51.
SURGICAL METHOD
1. Stripping of membranes-it results in increased activity of
prostaglandin F2alpha and phopholipase A2  and release of
prostaglandins during dilatation of cervix.
2. Amniotomy-it releases prostaglandins locally but this alone
cannot be used for induction of labour.
PHARMACOLOGICAL METHOD OF CERVICAL RIPENING
1. Misoprostol is PGE1 analogue. Not approved by U.S Food
and Drug administration. 25 mcg of intravaginal misoprostol
used every 4-6 hours for cervical ripening. Risk is
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
21
tachysystole. There are higher rates of vaginal delivery  and
literature indicates misoprostol as an effective agent for
cervical ripening52.
2. Mifepristone- its antiprogesterone. Labour induction is
successful with mifepristone but about foetal outcomes data
is insufficient53
3.  Oxytocin- the advantage is that induces contractions similar
to natural labour
4. Prostaglandin E2 analogue
VARIOUS ROUTES OF PGE2 ADMINISTRATION
INTRAVENOUS PGE2
This mode of delivering PGE2 is not in use, because small margin
between the doses that causes contractions and hyperstimulation.54
Thermogenic effects of PGE2 are difficult to differentiate from
chorioamnionitis.
EXTRA-AMNIOTIC PGE2
Insertion of endo-cervical gel into above internal os but increased
uterine response is seen in these preparations.
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ORAL PGE2
In 1970 it was popular, but higher levels of oral PGE2 is required
than other routes and vomiting was common.55
ENDOCERVICAL PGE2 GEL
Otherwise known as intracervical gel. Prepedil and cerviprost are
available commercially.It reduces cervical resistance  and  dilates the
cervix and reduces rate of failed induction56. Hyperstimulation is more
with endocervical PGE2 than others.
VAGINAL PGE2 GEL
It causes ripening of cervix , used in doses of 1-3mg/dose. Trail
study has proved oxytocin need is 3 times less in women primed with
vaginal PGE2 gel and no case of hyperstimulation.57
CERVIPRIME GEL
Dinoprostone 0.5 mg/3 g of gel is the active component of PGE2
gel. Other components are triacetin USP (2760 mg/3 g) and colloidal
silicon dioxide (240 mg/ 3g).  Chemical name is 11, 15-Dihydroxy-9-
oxo-prosta-5, 13-dien-1-oic acid. Dinoprostone instilled intracervically
acts on uterine myometrium and cause contractions similar to
spontaneous onset of labour. Vomiting and diarrhoea are due to
stimulation of smooth muscles of gastrointestinal tract by dinoprostone.
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Elevated body temperature seen with dinoprostone gel in Humans and
lowered blood pressure in animals with larger doses of dinoprostone.
Local action is cervical ripening and decreases cervical resistance. After
induction active metabolite 13, 14-dihydro-15-keto-PGE2 in plasma in
0.5 to 0.75 hours. PGE2 is metabolized in lungs, liver and kidney. PGE2
gel is brought to room temperature (150to300 C or 590to860 F).
Category C drugs- its embryo toxic and causes skeletal anomalies
in rats and rabbits.
MODE OF APPLICATION
Before application assembly has to be done. The protective end cap
is removed and used as a plunger extension in the barrel of syringe. Endo
cervical catheter is selected after careful vaginal examination. Under
aseptic precautions sterile shielded catheter is removed from package. Fit
the catheter hub to syringe and catheter is filled with sterile gel and expel
air prior to instillation by pushing plunger assembly. The dinoprostone
gel is administered with patient in dorsal position. The contents are
instilled into cervix below level of internal os. When there is no
effacement 20 mm endo-cervical catheter is used and 10 mm catheter if
cervix is 50% effaced.
To minimize leakage of gel patient is rested in supine position for
15-30 minutes. The repeat dose is decided after 6 hours based on vaginal
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examination. Maximum recommended dose is 1.5 mg of dinoprostone gel
(7.5 ml of gel).Gel is available as sterile semi-translucent viscous
preparation. It has to be stored in refrigerator (360to460C  or  20 to  80F).
Side effects: fever, back pain, gastrointestinal side effects, uterine
contractility-maternal. Brady-cardia and Decelerations in foetus.
Prostaglandins cause contraction of myometrium due to increase in
intracellular calcium level.
TACHYSYSTOLE: Its complication of intra-cervical PGE2 gel.3-
5 contractions in 10 minute period is normal, when its >5 contractions in
10 minute period is tachysystole.
LABOUR INDUCTION
DEFNITION:” Labour induction is the stimulation of uterine
contractions before the spontaneous onset of labour, with or without
ruptured membranes”.
Global incidence -20 %( RCOG – Evidence based clinical guide
line number 9).
In USA-incidence of labor induction: 22.5%
Induction is indicated before spontaneous onset of labour when the
benefits to the mother or fetus outweigh continuation of pregnancy.
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Induction of labour is one of the most common interventions
practiced in modern obstetrics.
The reasons for rising rates of labour induction are as follows58
1. Widespread availability of cervical ripening agents.
2. Ability of physicians to estimate gestational age accurately
has improved with early dating scans and hence avoiding
iatrogenic prematurity.
3. Knowledge regarding methods and indications for labour
induction has improved.
4. Relaxed attitudes towards elective indications, both by
physician and patient
5. Litigation constraints.
CRITERIA FOR AN IDEAL INDUCING AGENT: 58
1. labour onset is achieved within shortest possible duration.
2. Lower incidence of failure rate.
3. Labour pain should not be greater than spontaneous labour
pains and should not require more analgesia.
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4. Perinatal morbidity should not be more compared to
spontaneous labour.
5. Caesarean and operative vaginal delivery rates should not be
more than  spontaneous labour.
Till now, no ideal inducing agent is available to fulfill the above
criteria.
Thus proper and careful selection of patients for induction has to be
done.
COUNSELLING COUPLE PRIOR TO INDUCTION
Counseling of patient and family prior to induction.
While counseling, the following should to be discussed:
1. The reason for induction and the risk associated with
continuation of pregnancy.
2. Explain about arrangements for support during labour
3. Time and procedure of induction.
4. Pain relief measures since induced labour is more painful
than spontaneous labour.
5. The risks with induction of labour.
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
27
6. Regarding close monitoring of fetal heart rate and electronic
fetal monitoring in labour
7. If patient refuses induction- counsel about other options.
8. If induction fails counsel about other options available.
INDUCTION OF LABOUR IS RECOMMENDED IN
1. Prolonged pregnancy
2. Prelabour rupture of membranes
3. Hypertensive disorders of pregnancy- Gestational
hypertension, preeclampsia or eclampsia or Hypertension.
4. Fetal macrosomia.
5. Maternal request (1-3%) (WHO guidelines 1-5)
6. Gestational diabetes mellitus
7. Intrauterine fetal death (IUD) (6-7 NICE clinical guidelines
70-induction of labour)
8. Chorioamnionitis.
9. Intrauterine growth restriction (IUGR).
10. Maternal medical indications-
Diabetes mellitus,
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Cholestasis of pregnancy
Renal disease,
Chronic pulmonary disease and
Antiphospholid antibody syndrome.
11. Isoimmunization
12. Oligohydramnios
13. Elective induction- maternal social or geographical factors.
(e.g.distance from hospital and psychosocial factors) [ACOG
guidelines 8-13]
CONRAINDICATIONS FOR LABOUR INDUCTION
1. Prior classical uterine incision or prior transfundal uterine
surgery.
2. Antepartum hemorrhage/Placenta previa/Unexplained
vaginal bleeding.
3. Umbilical cord prolapse.
4. Transverse or oblique lie. (ACOG guidelines)
5. Cephalopelvic disproportion / pelvic structural deformities.
6. Active genital herpes infection.
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7. Invasive cervical carcinoma.
8. Hypersensitivity to cervical ripening agents
INDUCTION OF LABOUR NOT RECOMMENDED IN
Breech presentation
Severe fetal growth restriction (NICE clinical guidelines 70-
induction of labour)
Multiple pregnancy
Asthma, Glaucoma
Breech presentation
Polyhydramnios
Severe hypertension
Maternal heart disease
EVALUATION BEFORE INDUCTION OF LABOUR59
MATERNAL CRITERIA
1. Confirm indication for induction.
2. Clinical pelvimetry to assess pelvic adequacy.
3. Assessment of cervical favourability (Modified Bishop’s
score)
4. Review contraindications to vaginal delivery.
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FETAL CRITERIA
1. Confirm gestational age.
2. Estimate fetal weight (by clinical or ultrasound examination)
3. Determine fetal presentation.
4. Confirm fetal well-being.
5. Assess need to document fetal lung maturity status.
CRITERIA FOR CONFIRMATION OF GESTATIONAL AGE
AND FETAL LUNG MATURITY
CONFIRMATION OF GESTATIONAL AGE
1. Fetal heart tones have been documented >30 weeks by
Doppler ultrasound.
2. >36 weeks since a positive serum or urine human chorionic
gonadotropin pregnancy test.
3. Ultrasound measurement at less than 20 weeks of gestation
supports gestational age >39 weeks.
FETAL LUNG MATURITY:
If term gestation cannot be confirmed by two or more of the above
criteria amniotic fluid analysis can be done to provide evidence of fetal
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lung maturity. The parameters for evidence of fetal pulmonary maturity
are as follows:
1. Lecithin / sphingomyelin (L/S) ratio>2.1
2. Presence of phosphatidyl glycerol (PG).
3.  TDXFLM  assay  >70  mg  surfactant  per  1  kg  of
albumin present.
4. Presence of saturated phosphatidylglycerol choline
(SPC)  >500 ng/mL for pregestational dibetic patients.
5. Lamellar body count >30,000/mcL.
PREINDUCTION CERVICAL ASSESSMENT
Success of labour induction depends on favourability of cervix.
The goal of cervical ripening is to facilitate  the process of cervical
softening, effacement and dilatation thus reducing induction delivery
interval.
When there is indication for induction and cervix is
unfavourable,cervical ripening agents are used.
The status of cervix is determined by Bishop’s scoring system.
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
32
Calkin and colleagues caried out systematic studies of the factors
influencing duration of first stage of labour. They concluded that the
length, thickness and consistency of cervix are important factors.
The modified Bishop’s score   is the most commonly used system
for evaluation of cervix before induction.
In 1964, Bishop proposed a scoring system to know about
suitability of women for induction of labour.60
This pelvic score was based on following parameters as follows: 61
0 1 2 3
Dilatation 0 1-2 3-4 5-6
Effacement% 0-30 40-60 60-70 80+
Station -3 -2 -1/0 +1/+2
Consistency Firm Medium Soft
Position Posterior Mid position Anterior
Bishop’s score done to increase predictability of successful
induction.
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Modified Bishop’s score (Calder 1974)
0 1 2 3
Dilatation(cm) <1 1-2 2-4 >4
Effacement
(%)
>4 2-4 1-2 <1
Station(cm) -3 -2 -1,0 +1/+2
Consistency Firm Average Soft
Position Posterior Mid-
anterior
Bishop’s score of 9 indicates likelihood of successful induction and
score of 4 or less identifies unfavourable cervix and indicates cervical
ripening. As Bishop’s score decreases there is increased rate of
unsuccessful induction.
CERVICAL EXAMINATION
EFFACEMENT:  The degree of effacement is expressed as length
of cervical canal. Cervix is 100% effaced when it’s thin and lie adjacent
to lower uterine segment.
DILATATION: is estimated by measuring the diameter of cervical
opening from one margin of cervical opening to other margin. The
maximum diameter that the cervix can dilate is 10 cm.
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POSITION:   Its  relationship  of  cervical  os  and  Posterior,  Mid
position and anterior are the categories.
CONSISTENCY: Soft, medium and firm
STATION: The level of foetal presenting part in relationship to
ischial spines is station. When presenting part at level at level of ischial
spines its zero station, above it is -1,-2,-3 and below it is +1, +2, +3.
BURNETT’S MODIFICATION OF BISHOP’S SCORE: 62
FACTOR 0 1 2
Dilatation <1.5 1.5-3 >3
Station -2 or higher -1 0 or lower
Position Posterior Mid Anterior
Effacement(cm) 1.5 or more Intermediate 0.5 or less
Consistency Firm Intermediate Soft
The maximum score given by Burnett is 10 and each parameter
given maximum score of 2. He considered previous term birth and
cephalic presentation are indications and previous uterine surgery as a
contraindication for induction. When scoring is 6 to 8 they deliver within
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6 hours,  and when its  9-10 they deliver  within 4 hours.  Score of  <6 are
unfavourable.
FIELD’S System for rating readiness for induction63
0 1 2
Timing of
induction Versus
EDC(weeks)
Uncertain or >3
weeks prior
1-3 weeks prior Within 1
week
Attitude Objects/fear Hesitates/accepts Enthusiastic
Expected foetal
weight(grams)
<2,500 Uncertain >2,500
Uterine tone on
palpation
Flaccid Some tone Firm
Softness of cervix Firm Firm, Somewhat
soft
Soft
Effacement (%) <80 80 >80
Position of cervix Posterior 45 degree to
vaginal axis
Towards
vulva
Station of
presenting
part(cm)
-2 or higher -1 to 0 +1 or lower
Dilatation 0-1 2-3 >3
Vaginal discharge No change Increased Blood
tinged
EDC: Expected date of confinement.
When score is 16 or more it’s favourable for induction.
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FAILED LABOUR INDUCTION
Friedman’s studies have shown that failure of transition from latent
to active phase is failed labour induction. Regular and painful
contractions are not associated with cervical changes or active phase is
not attained with 12 hours of oxytocin infusion (20mu/min) is failed
induction.
LABOUR DURATION
Labour induction is done in unfavourable cervix.  Cervical dilation
at time of admission is an important factor determining latent phase
duration. Active phase of labour in induced labour is shorter or same in
compared to spontaneous labour. The transition from latent to active
phase depends on uterine activity and cervical dilation.
UTERINE ACTIVITY
Uterine activity is measured by Montevideo units (MU) and its
product of intensity/amplitude and frequency of each contraction (number
of contractions in 10 minute interval). Caldeyro-Barcia illustrated that
uterus maintains resting pressure of 20 mm of Hg before 30 weeks. There
is an increase in frequency, intensity and coordination of uterine
contractions after 30 weeks. Uterine activity in beginning of labour is
between 80-120MU and in normal labour the range of uterine activity is
between 75-375MU.
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Uterine activity integral is most widely used method. It includes
contraction frequency, strength and duration over 10 minute period. It’s
measured in kilopascal second (kpas).The rate of cervical dilatation is
mainly determined by mean active pressure.
ULTRASOUND ASSESSMENT OF CERVICAL LENGTH:
TRANSABDOMINAL ULTRASOUND:
Cervical length was measured initially by Trans abdominal
ultrasound. But the disadvantages are as follows
Pre-requisite for Trans abdominal measurement of cervical length
is distended bladder.
Bladder distension distorts cervical length and falsely lengthens the
cervix obscuring the funnelling.
The resolution is further altered by maternal obesity and shadowing
from foetal parts.
 Probe to cervix distance is long and clear visualisation of cervix is
hampered.
Hence it’s less reliable method for evaluating cervical length.
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TRANSPERINEAL ULTRASOUND
Otherwise known as translabial ultrasound measurement of
cervical length.
The patient is positioned on table with hips and knees flexed and
the gloved transducer is placed over the perineum in a sagittal orientation
between labium majora.
Pre-requisite is empty bladder and foetal parts does not interfere
with visualisation of cervix.
ADVANTAGES
Transducer is close to cervix and no need for entry into vagina;
hence pressure over cervix is avoided.
Compliance by the pregnant patient is good.
DISADVANTAGES
External of is obscured by rectal gas.
Visualisation of cervix is poor compared to trans-vaginal
ultrasound.
TRANSVAGINAL ULTRASOUND
Gold standard technique for evaluation of cervix.
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It’s an objective method to assess cervical length and to detect
changes in internal os.
MRI measurement of cervical length is comparable to the trans-
vaginal cervical length measurement. But MRI is expensive and
possesses potential hazards in women with ferromagnetic foreign
bodies.64
RECOMMENDATIONS FOR TRANSVAGINAL CERVICAL
LENGTH MEASUREMENT ARE AS FOLLOW:
1. Empty bladder
2. Trans-vaginal probe is covered by condom (to prevent cross
infection among patients). Operator should use sterile hand glove for self-
protection. In an over anxious patient ask the patient herself to place
probe in vagina.
3. Trans-vaginal probe is placed in anterior fornix and cervical
length is measured in sagittal plane with long axis viewing echogenic
endo-cervical mucosa along entire length of cervical canal.
4. Manipulate until entire cervical canal is visualized from
external os to internal os (Diameter of cervical canal measured at the
level of cervical canal meeting the amniotic sac) along endo-cervical
canal. Avoid undue pressure over cervix to avoid false lengthening of
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cervix. If echogenicity of cervix is increased it indicates excessive
pressure, withdraw the probe and reapply.
4. Cervical length is measured three times in succession and
shortest of the three is taken as cervical length in millimetres. Cervical
length can be measured either as a sum of 2 straight lines that follows the
curve (when deviation of canal is more than 5 mm) or straight line
between internal and external os.
5. Transfundal pressure is applied for 15 seconds and changes
in cervical length and funnelling is noted(Funnelling or wedging is any
triangle V/U at the area of internal os with apex anywhere along cervical
canal).
FOR BETTER RESULTS
1. External os should be symmetrically visible and internal os
at isosceles angle.
2. The endo-cervical canal has to be seen from internal os to
external os.
3. Increased echogenicity of cervix is avoided because it
indicates excessive pressure.
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ANATOMIC DIFFICULTIES
1. Myometrial contractions interfere with visualisation of
internal os and hence cervix appears longer.
2. Cervical length may change during examination.
3. Endo-cervical polyps and mucus in the canal cause
separation of anterior and posterior borders and cervix
appears shorter.
TECHNICAL DIFFICULTIES:
1 Minimal pressure over cervix causes elongation of cervix.
2. Experienced persons several diagonal angles can be obtained
providing shorter cervical length than in true sagittal plane.
CERVICAL LENGTH AT DIFFERENT GESTATIONAL AGE
Gestational age Cervical length
20 weeks 40 mm
24 weeks 35mm
34 weeks 34mm
Term (37-42 weeks) 28mm
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OTHER BENEFITS OF TRANSVAGINAL SONOGRAPHIC
MEASUREMENT OF CERVICAL LENGTH
1. PRETERM LABOUR: 64
Shorter the cervix more the risk of preterm labour. The cervical
length <2.5 cm at 24 weeks is the most important predictor of preterm
birth.
2. CERVICAL LENGTH IN TWIN GESTATION:
Trans-vaginal sonographic measurement of cervical length at 24-26
weeks if>35 mm indicates they are at low risk for delivering before 34
weeks.
3. CERVICAL LENGTH IN WOMEN WITH ENCIRCLAGE:
Trans-vaginal circlage is placed in middle part of cervix.
Measurement of cervical length in post encirclage patients showed
increase in length compared to pre-encirclage. If cervical length is
<2.5cm and <1cm in the portion above cerclage are best predictors of
preterm birth.
4. TRANSVAGINAL CERVICAL LENGTH IN THOSE WITH
SUSPECTED PRETERM LABOUR65:
Measurement of cervical length in symptomatic patients decreased
incidence of admission in hospital and cost but not preterm births.
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5. PPROM:
The latency period between 24-32 weeks is 2 days if cervical
length is 20mm and 6 days if length is>20mm.
FOETAL FIBRONECTIN (FFN)
FFN is glycoprotein found in placental tissue, decidua basalis and
amniotic fluid. Before amnion and decidua fuses FFN is present in
cervicovaginal secretions at 16 weeks. It disappears after 22 weeks. If
FFN appears again indicates disruption of choriodecidual interface.
Another non-invasive modality to assess changes in cervix is
cervical water content MRI.
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MATERIALS AND METHODS
STUDY DESIGN
Prospective observational study.
PLACE OF STUDY
ESI PGIMSR, KK Nagar, Chennai.
PERIOD OF STUDY
JAN 2012 to NOV 2013.
INFORMED CONSENT
For trans-vaginal ultrasound and induction of labour.
SAMPLE SIZE : 250.
95% Confidence interval and 5% precision sample is 250. The
pregnant women with Gestational age between 37-42 weeks decided for
cerviprime induction has been taken in the study.
FORMULA: Z2 (P [1-P])/d2.
INCLUSION CRITERIA:
Singleton live cephalic presentation.
Reactive CTG.
Bishop’s score<4
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Rh negative pregnancy,
Pre-eclampsia,
Gestational diabetes mellitus,
Post-dated pregnancy.
Patients who had given consent for study.
EXCLUSION CRITERIA:
Antepartum haemorrhage,
Previous uterine surgeries.
Heart disease complicating pregnancy,
Cephalopelvic disproportion,
Bronchial asthma.
Glaucoma,
Hepatic and renal disease.
Hypersensitivity to prostaglandins.
In spontaneous onset of labour.
METHODOLOGY
All antenatal women under inclusion criteria are subjected to
digital examination to determine Bishop’s score. Total score is 12.
Women with Bishop’s score of <4 are induced PGE2 gel.
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Before induction trans-vaginal sonographic measurement of
cervical length is done after getting informed consent for trans-vaginal
cervical length and induction of labour. Trans-vaginal cervical length is
measured with LOGICQC Series machine with 6MHZ trans-vaginal
probe.
PRE-REQUISITES are
           1. Empty bladder (for clear visualization of cervix).
           2. No spontaneous uterine contractions.
Cervical length is measured in sagittal plane with trans-vaginal
probe in anterior fornix of cervix. Manipulate till entire cervical canal is
visualized from internal to external os in a straight line. Cervical length is
measured 3 times in succession. Shortest length of three values obtained
is used for analysis. Diameter of cervical canal is also measured at the
level of internal os where cervical canal meets the amniotic sac.
Funnelling/Wedging (Any triangle v/u at the area of internal os with apex
along cervical canal) is also noted.
MODE OF APPLICATION OF PGE2 GEL
Bladder is emptied and foetal heart rate is recorded. With patient in
lithotomy position 0.5 mg of PGE2 gel is applied intracervically under
aseptic precautions. Foetal heart rate is recorded before and after
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application of PGE2 gel. Patient is rested in lateral position for 30
minutes. Dose is repeated after 8 hours interval. Maximum is 3 doses.
Before each dose of PGE2 gel cervical length is measured trans-
vaginally. Subsequent dose is withheld
If patient is active labour.
when contractions are regular (3 in 10 minutes)
In active phase of labour artificial rupture of membranes was done
with 4 cm dilated and 80% effaced. Successful induction is occurrence of
active labour within 72 hours of induction. Failed induction is inability to
achieve the active phase within 72 hours from initiation of induction.
Failure to progress is when there is no cervical dilatation for 2 hours in
active phase and no foetal descent for 1 hour in stage with adequate
uterine contractions. Its indication for caesarean section.
PRIMARY OUTCOME
* Trans-vaginal cervical length that predicts Successful vaginal
delivery within 72 hours of induction.
SECONDARY OUTCOME
* Duration of latent phase
* Total labour duration
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
48
RESULTS
250 women with gestational age of 37-42 weeks were enrolled in
the study and induction with PGE2 gel is done after measuring trans-
vaginal cervical length. Demographic variables are summarized.
TABLE – 1 : AGE DISTRIBUTION
Age group
Cases
No %
Up to 20 years 10 4.0
21-25 years 105 42.0
26-30 years 109 43.6
31-35 years 26 10.4
Total 250 100
Range 18-35 years
Mean 25.9 years
SD 3.5 years
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GRAPH – 1 : AGE DISTRIBUTION
Range of pregnant women in the study is between 18-35 years.
Maximum number of women in our study group is between 26-30 years
(44%).
GRAPH - 1A : AGE DISTRIBUTION.
Bar chart showing the maximum number of women in study group
between 26 to 30 years.
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TABLE – 2 : OBSTETRIC SCORE
Obstetric score
Cases
No %
Primigravida 164 65.9
Multigravida 86 34.1
Total 250 100
The maximum number of women requiring induction in our study
group is primi with (65.9%). Multiparous women requiring induction is
34.1%.
GRAPH : 2 - OBSTETRIC SCORE
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TABLE - 2A: OBSTETRIC SCORE AND MODE OF DELIVERY
Obstetric
Score
Total
cases
Mode of delivery
Normal delivery LSCS
No. % No. %
Primi 164 71 43.2% 93 56.7
Multi 86 63 73.3 23 26.7
‘p’ < 0.0001 Significant
In Primiparous women 43.2% deliver vaginally and 56.7% by
LSCS but in multiparous women 73.3% deliver vaginally and 26.7% by
LSCS. It indicates that parity is an independent predictor of vaginal
delivery.
GRAPH - 2A : PARITY AND MODE OF DELIVERY
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TABLE – 3 : HEIGHT/ WEIGHT/ BMI
The Average Height And Weight Of Pregnant Women In Our
Study Is 154.2 Cm And 56.3 Kg Respectively
Variables Range Mean SD
Height (in cm) 138-169 154.2 5.4
Weight (in kg) 40-119 56.3 9.4
BMI 17.7 – 52.8 25.0 3.8
TABLE - 3A : B M I AND MODE OF DELIVERY
B M I Total cases
Mode of delivery
Normal delivery LSCS
No. % No. %
Upto 20 9 7 77.8 2 22.2
20.1 – 25 137 90 65.7 47 34.3
25.1 – 30 88 32 36.4 56 63.6
Above 30 16 5 31.3 11 68.8
Mean BMI
S.D.
24.23
3.72
25.86
3.81
‘p’ < 0.0001 Significant
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GRAPH – 3 : HEIGHT/ WEIGHT/ BMI
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TABLE - 4 : GESTATIONAL AGE
Parameter Gestational age (in weeks)
Range 37 weeks to 41 weeks +5 days
Mean 39.59 weeks
SD 0.96
Pregnant women induced with cerviprime gel is in our study is
between 37 to 42 weeks of gestation.
GRAPH – 4 : GESTATIONAL AGE
The mean gestational age of induction is 39.6 weeks in study
0
5
10
15
20
25
30
35
40 39.61
M
ea
n 
va
lu
es
(w
ee
ks
)
GESTATIONAL AGE
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
55
TABLE – 5 : INTERVAL SINCE LAST CHILD BIRTH
In multiparous women average interval since last child birth is 4.5
years.
Parameter
Interval since last child birth
(years)
Range 2-10
Mean 4.58
SD 2.63
TABLE – 6 : RISK FACTORS
Risk factors
Cases
No %
Anaemia 10 4.0
DM on insulin 2 0.8
GDM on insulin 22 8.8
GDM on Meal plan 19 7.6
Epileptic 1 0.4
Gestational hypertension 9 3.6
HBS AG+ 2 0.8
Hypothyroid 5 2.0
Pre eclampsia 15 6
Rh negative 6 2.4
Sickle cell trait 1 0.4
Total cases with risk factors* 37* 14.8
Total cases without risk factors 213 85.2
Total 250 100
Most of the cases had more than one risk factor.
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GRAPH - 6 : RISK FACTORS
85.2%  of  Women  in  study  have  no  risk  factors  and  14.8%  of
women with risk factors.
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TABLE - 6A : RISK FACTOR AND MODE OF DELIVERY
The presence/absence of risk factors and mode of delivery by
vaginal or caesarean section is not statically significant.
Risk factor
Total
cases
Mode of delivery
Normal delivery LSCS
No. % No. %
Present 37 19 51.4 18 48.6
Absent 213 115 54 98 46
‘p’
0.9056
Not Significant
GRAPH - 6A : RISK FACTORS AND MODE OF DELIVERY
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TABLE - 7 : NON STRESS TEST
All women included in our study NST is reassuring before
induction.
Non stress test
Cases
No %
Reassuring 250 100
Others 0 0
Total 250 100
TABLE - 8 : AMNIOTIC FLUID INDEX AND BISHOPS SCORE
Parameter Amniotic fluidindex Bishop score
Range 2-17 0-4
Median 8 3
Mean 8.41 2.74
SD 2.5 1.2
The average bishop score of women undergoing induction in our
study group is 2.74 and amniotic fluid index is 8.41.
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GRAPH - 8A : AMNIOTIC FLUID INDEX/ BISHOP’SCORE
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TABLE - 8B : BISHOP SCORE AND MODE OF DELIVERY
Bishop Score
Total
cases
Mode of delivery
Normal delivery LSCS
No. % No. %
0 15 2 13.3 13 86.7
1 28 3 10.7 25 89.3
2 49 14 28.6 35 71.4
3 74 46 62.2 28 37.8
4 84 69 82.1 15 17.9
TABLE – 9 : INDICATION FOR INDUCTION
Indication for induction
Cases
No %
On due 35 14.0
Oligo-hydromnios 29 11.6
GDM – on insulin 22 8.8
GDM – on mean plan 19 7.6
DM – on insulin 2 0.8
Gestational hypertension 9 3.6
Prolonged pregnancy 85 34.0
Pre-eclampsia 15 6.0
Pre mature rupture of membranes 27 10.8
Rh negative 6 2.4
IUGR 1 0.4
Total 250 100
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GRAPH – 9 : INDICATION FOR INDUCTION
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RECEIVER OPERATING CHARACTERISTIC CURVE (ROC) TO
FIND OUT CUT OFF VALUES OF TRAN’S VAGINAL
CERVICAL LENGTH FOR NORMAL DELIVERIES
Case Processing Summary
Mode Valid n (listwise)
Positive 116
Negative 134
Larger values of the test result variable(s) indicate stronger
evidence for a positive actual state.
a. The positive actual state is LSCS
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COORDINATES OF THE CURVE
Test Result Variable(s) : Trans vaginal cervical length with 97.4
Sensitivity and 97.8 Specificity.
Positive if Greater
Than or Equal Toa Sensitivity 1 – Specificity
.500 1.000 1.000
1.550 1.000 .993
1.650 1.000 .985
1.750 1.000 .978
1.850 1.000 .970
1.950 1.000 .955
2.050 1.000 .903
2.150 .974 .888
2.250 .974 .828
2.350 .974 .776
2.450 .974 .590
2.550 .974 .537
2.650 .974 .022
2.750 .767 .000
2.850 .681 .000
2.950 .586 .000
3.050 .491 .000
3.150 .379 .000
3.250 .155 .000
3.350 .103 .000
3.450 .052 .000
4.500 .000 .000
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Area Under the Curve
Test Result Variable(s): Trans vaginal cervical length
Area Std. Errora AsymptoticSig.b
Asymptotic 95% Confidence
Interval
Lower Bound Upper Bound
.975 .013 .000 .948 1.000
For 97.5% of the cases included in the Study, the Trans vaginal
cervical  length  was  less  than  the  ROC  cut  of  value  (2.65  cm)  for  the
normal deliveries and more than the cut off value for the LSCS
cases.AUC=0.975.
TABLE – 10 : TRAN’S VAGINAL CERVICAL LENGTH
Trans vaginal cervical length
Cases
No %
<2.65 cm 134 53.6
>2.65 cm 116 46.4
Total 250 100
Range 1.5 – 3.5 cm
Mean 2.71 cm
SD 0.38 cm
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GRAPH : 10 - TRANSVAGINAL CERVICAL LENGTH AND
MODE OF DELIVERY
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TABLE - 10A: TRAN’S VAGINAL CERVICAL LENGTH AND
MODE OF DELIVERY
(Cut off value as per ROC Curve)
Trans vaginal
cervical length
(cut off value as per
ROC curve)
Total
cases
Mode of delivery
Normal delivery LSCS
No. % No. %
< 2.65 cm 134 131 97.8 3 2.2
>2.65 cm 116 3 2.6 113 97.4
‘p’
< 0.0001
Significant
GRAPH - 10A: TRAN’S VAGINAL CERVICAL LENGTH AND
MODE OF DELIVERY
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TABLE – 11 : INDUCTION DELIVERY INTERVAL
The mean induction delivery interval in our study is 20 hours (2.2-
73.2 hours).
Induction delivery interval
Cases
No %
0-24 hours 177 70.8
24- 48 hours 58 23.2
48-72 hours 15 6
Range 2.2 – 73.2 hours
Mean 20.1 hours
SD 15.0 hours
TABLE  - 11A : INDUCTION TO DELIVERY INTERVAL
Duration of
delivery
Duration
Normal deliveries
LSCS
deliveries
‘p’
Mean S.D. Mean S.D.
Latent phase 13.1 9.3 25.2 17.9 <0.0001
Significant
Active phase 126.4 96 131.1 68 0.5507
Not significant
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GRAPH - 11: INDUCTION TO DELIVERY INTERVAL
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TABLE – 12 : NUMBER OF DOSES OF PGE2 GEL AND MODE
OF DELIVERY
Number doses
of PGE2 gel
Total
cases
Mode of delivery
Normal delivery LSCS
No. % No. %
1 119 77 64.4 42 35.6
2 76 47 61 30 39
3 55 11 20 44 80
TABLE - 12A : NUMBER OF DOSES OF PGE2
Maximum number of women in our study group one gel is used
(47.6%)
Number of doses
of PGE2 gel
Cases
No %
1 119 47.6
2 76 30.4
3 55 22.0
Total 250 100
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GRAPH : 12 - NUMBER OF DOSES OF PGE2 GEL
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TABLE – 13 : MODE OF DELIVERY
Mode of delivery
Cases
No %
LSCS 116 46.4
Normal vaginal delivery 103 41.2
Vacuum 20 8.0
Forceps 11 4.4
Total 250 100
GRAPH - 13: MODE OF DELIVERY
In our study 53.6% of women delivered vaginally and 46.4%
delivered by LSCS.
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TABLE – 14 :  INDICATION FOR LSCS
In our study the maximum number of women underwent LSCS for
fetal distress (50%)
Indication for LSCS
( n  =116)
Cases
No %
Fetal distress 58 50
Failed induction 39 33.6
Meconium stained liquor 6 5.2
Non progression of labor 3 2.6
Protracted Descent 3 2.6
PROM 2 1.7
Others 5 4.3
Total 116 100
GRAPH – 14 : INDICATION FOR LSCS
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TABLE - 15 : COMPLICATIONS OF PGE2 GEL
The most common complication in our study group is postpartum
hemorrhage (11%)
Complications of PGE2 Gel CasesNo %
Complete perineal tear 1 0.4
Manual removal of placenta 3 1.2
Para-urethral tear 1 0.4
Post-partum hemorrhage 11 4.4
Pre mature rupture of membranes 1 0.4
Sphincter injury(External anal sphincter) 1 0.4
Tachy–systole 1 0.4
Total cases with complications 19 7.6
Total cases without complications 231 92.4
Total 250 100
GRAPH – 15 : COMPLICATIONS OF PGE2 GEL
19
231
0
COMPLICATIONS OF PGE2 GEL
PRESENT ABSENT
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
74
TABLE – 16 : BIRTH WEIGHT
The average birth weight of baby in our study group is 2.69 kg.
Birth weight
Cases
No %
<2.5 kg 18 7.2
>2.5 kg 232 92.8
Range 1.72 - 4 kg
Mean 2.69 kg
SD 0.37 kg
GRAPH – 16 : BIRTH WEIGHT
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TABLE – 17 : APGAR SCORE
The maximum number of babies in our study group had good
APGAR of 8/10 (81.6%)
Apgar score
Cases
No %
6/10 5 2.0
7/10 39 15.6
8/10 204 81.6
9/10 2 0.8
Total 250 100
GRAPH – 17 : APGAR SCORE
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TABLE - 18 : COMPLICATIONS OF BABY
The most common complication for neonate in our study group is
meconium stained amniotic fluid (10.4%)
Complications of baby
Cases
No %
Meconium Stained Amniotic fluid 26 10.4
Respiratory distress 12 4.8
IUGR 9 3.6
Infant of diabetic mother 8 3.2
TTN 5 2.0
HIE 3 1.2
Other complications 5 2.0
Total cases with complications 68 27.2
Total cases without complications 182 72.8
Total 250 100
TABLE – 19 : NICU ADMISSIONS
Rate of NICU admission in our study group is 22%.
NICU admissions
Cases
No %
Yes 55 22
No 195 78
Total 250 100
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GRAPH - 19 : NICU ADMISSION
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TABLE – 20 : DURATION OF DELIVERY
The mean latent phase duration is 18.7 hours and active phase
duration is 2.1 hours
Variables
Duration ( in hours)
Range Mean SD
Latent phase 0.75 - 72.2 18.7 15.2
Active phase 0.25 – 14 2.1 1.5
GRAPH - 20: DURATION OF DELIVERY
0
2
4
6
8
10
12
14
16
18
20
LATENT
PHASE
ACTIVE
PHASE
18.7
2.1M
ea
n 
du
ra
tio
n 
(h
ou
rs
)
DURATION OF DELIVERY
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
79
DISCUSSION
In our study group, women undergoing induction of labour are at
37-42 weeks of gestation. The mean gestational age of induction in our
study is 39.5 weeks (Range 37-40 weeks). PANDIS et al66 conducted
study to predict successful vaginal delivery before induction by
measuring trans-vaginal cervical length before induction. Here mean
gestational age is 41 weeks (range from 37-42 weeks).
Among 250 women in our study 164(65.9%) are nulliparae and
86(34.1%) are multiparae.
Indications for induction in our study:
Prolonged pregnancy (n=85)
On due date (n=35)
Oligo-hydramnios (n=29)
Pre labour rupture of membranes (n=27)
GDM on insulin (n=22)
GDM on meal plan (n=19)
Pre-eclampsia (n=15)
Gestational hypertension (n=9)
Rh negative pregnancy (n=6)
DM on Insulin (n=2)
IUGR (n=1)
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MODE OF DELIVERY
 In our study 53.6% delivered vaginally and 46.4% by LSCS in 72
hours after induction. The higher rate of LSCS is due to use of continuous
fetal heart rate monitoring in induced patients.
ROC CURVE
It was constructed for sonographically measured cervical length
and more than 450 line indicating significant relationship between
variable and successful induction. Area under Curve (AUC) =0.975 and P
value is<0.0001 hence statistically significant.
Best cut-off value for prediction of successful vaginal delivery
within 72 hours of induction in our study is 2.6 cm with 97.4%sensitivity
and 97.8% specificity. Pandis et al66 studied 240 women and measured
trans-vaginal cervical length to predict successful labour induction.ROC
curve analysis was done and proved cervical length is better predictor
with sensitivity of 87% and specificity of 71% for length of <2.8cm.
Soong  Ha  et  al67 studied 105 women and trans-vaginal
ultrasonography done for cervical assessment and concluded that trans-
vaginal cervical length is an independent predictor of successful labour
induction  with  sensitivity  of  75%  and  specificity  of  83%  for  length  of
<3cm.
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* Ibrahim et al68 studied 120 women and concluded that
cervical length measured trans-vaginally is less in women
delivered vaginally than those delivered by LSCS.
* Maitra  et al 69 studied 120 women and proved that cervical
length measured trans-vaginally before induction is an
independent predictor of successful vaginal delivery at<3
cm.
* Keepanasseril  et al70 studied 138 women and concluded that
best cut-off point in ROC curve for predicting successful
labour induction is 3 cm.
* Limitation is that to obtain trans-vaginal cervical length,
equipment is expensive and technical expertise is required
for measuring cervical length to avoid errors. In setting
where equipment and expertise is available it can be done
with minimal discomfort to patient. It can predict successful
vaginal delivery and helps in counseling the patient. Cervical
length of <2.6 cm have more chance of normal delivery than
those with>2.6 cm.
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* In our study successful vaginal delivery from
0-24 hours=62.1%.PitarelloPda R. et al71 study done a study
showing 62.6% showing normal deliveries within 24 hours of induction.-
24-48 hours = 39.7%
48-72 hours = 6.7%
In our study LSCS
0-24 hours = 37.9%
24-48 hours = 60.3%
48-72 hours = 93.3%.
In our study 62.1% delivered normally within 24 hours of
induction. The number of normal deliveries decreases as induction
delivery interval increases. The number of caesarean deliveries increases
as induction delivery interval increases.
DURATION OF LATENT PHASE
The mean duration latent phase in our study is 18.7(range 0 .75 to
72.2 hours) hours and mean duration of active phase of labour is 2.1
hours (range 0.25-14hrs).
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Soon Ha et al have done a study to evaluate value of trans-vaginal
cervical length in prediction of outcome of labour induction. The mean
duration of latent phase of  labour was 15.3 hours (range 1to 60 hours)
and the mean duration of active phase of  labour  is 4.1 hours (1-14
hours).
The component in labour most affected by cervical length during
induction is long latent phase.72
The mean latent phase duration in women undergoing LSCS in our
study is 25.2 hours and in normal vaginal delivery is 13.1hours and its
statistically significant (p<0.0001) in our study.73 Alabi  et  al   done  a
study to determine association between length of labour and mode of
delivery longer the duration of latent phase higher the risk of caesarean
section.
INDUCTION DELIVERY INTERVAL
The mean induction delivery interval in our study is 20.8 hours.
Rane  et al  done similar study and the induction to delivery interval was
15.5 hours and  cervical length measured trans-vaginally have significant
effect on induction delivery interval within 24 hours.
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Boozarjomehri et al73  measured trans-vaginal cervical length of 53
women before induction and co-related with length of latent phase and it
has no significant association with induction to delivery interval..
Soon Ha et al studied 105 women and assessed cervical length
trans-vaginally and concluded that cervical length is an independent
predictor of successful labour induction and duration of induction.
In our study about 70.8% (62%-vaginal deliveries) delivered within
24 hours of induction and as the induction delivery interval increases
number of normal deliveries decreases and LSCS increases and the
association is statistically significant (P value<0.0001).
LIMITATIONS OF THE STUDY
1. Our study involved both nulliparous and multiparous
women.
2. Other parameters of trans-vaginal cervical assessment like
funneling, cervical angle and dilatation are not included.
These parameters are also predictors of successful vaginal
delivery.
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CONCLUSION
Trans-vaginal cervical length can be used to predict successful
vaginal delivery in the setting where appropriate equipment and expertise
are available. Thus the traditional method of assessing the favorability of
cervix can be replaced by trans-vaginal cervical measurement and add yet
another dimension in field of obstetrics
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SUMMARY
The main objective of the study is pre-induction trans-vaginal
sonographic measurement of cervical length in prediction of successful
vaginal delivery.
It  is  a  prospective  observational  study  done  in  250  women  with
gestational age ranging from 37-42 weeks of gestation. Cervical length is
measured before induction by trans-vaginal ultrasound. Both primi and
multigravida are included in our study. Induction with PGE2 gel is done.
Results are analyzed with ROC curve, the cut-off value predicting
successful vaginal delivery is 2.6cm with sensitivity of 97.4% and
specificity of 97.8% within 72 hours of induction.
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ABBREVIATIONS
OBS.SCORE - OBSTETRIC SCORE
EDD - EXPECTED DATE OF DELIVERY
GA - GESTATIONAL AGE
LCB - LAST CHILD BIRTH
RISK FAC - RISK FACTOR
NST - NON STRESS TEST
AFI - AMNIOTIC FLUID INDEX
BISHOPS - BISHOPS SCORE
IOI - INDICATION FOR INDUCTION
TVL - TRANS VAGINAL CERVICAL LENGTH
NOD - NUMBER OF DOSES OF  PGE2 GEL
IDI - INDUCTION DELIVERY INTERVAL
MOD - MODE OF DELIVERY
COM - COMPLICATIONS OF PGE2 GEL
B.WT - BIRTH WEIGHT
COB - COMPLICATIONS OF BABY
NICU - NEONATAL INTENSIVE CARE UNIT
ADMISSION
LATENT - LATENT PHASE
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ACTIVE - ACTIVE PHASE
MSAF - MECONIUM STAINED AMNIOTIC FLUID
MSL - MECONIUM STAINED LIQUOR
HIE - HYPOXIC ISCHAEMIC
ENCEPHALOPATHY
PROM - PRE MATURE RUPTURE OF
MEMBRANCES
HYPOTHY - HYPOTHYROIDISM
PP - PROLONGED PREGNANCY
NVD - NORMAL VAGINAL DELIVERY
LSCS - LOWER SEGMENT CESEREAN SECTION
MAN R OF
PLACENTA - MANUAL REMOVAL OF PLACENTA
IUGR - INTRA UTERINE GROWTH
RETARDATION
NPL - NON PROGRESS OF LABOR
IDM - INFANT OF DIABETIC MOTHER
DM INS - DIABETES ON INSULIN
OD - ON DUE
OLIGO - OLIGOHYDRAMINOS
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FD - FETAL DISTRESS
PRE ECL - PRE ECLAMPSIA
F INDUCTION  - FAILED INDUCTION
F VENTOUSE  - FAILED VENTOSE
GEST.HT - GESTATIONAL HYPERTENSION
P DESCNT - PROCTRACTED DESCENT
CPT - COMPLETE PERINEAL TEAR
PPH - POST PARTUM HAEMORRAGE
VACUM - VACUM DELIVERY
GDM  M - GDM ON MEAL PLAM
GDM INS - GDM ON INSULIN
SC - SICKLE CELL TRAIT
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S.NO AGE IP.NO
OBS
SCORE EDD GA HEIGHT WEIGHT BMI LCB
RISK
FAC NST AFI BISHOP IOI TVL N.O.D IDI MOD LSCS-IND COM B.WT APGAR COB NICU LATENT ACTIVE
1 20 638 PRIMI 1/12/2012 40 156 45 20.8
ANAEMI
A R 5 1 OLIGO 3.5 1 11 HRS LSCS FD     - 2.7     8 / 10 TTN AD 11HRS _
2 20 3165 PRIMI 1/10/2012 40+1 158 57 25.3
PRE-
ECL R 8.8 2 PP 2.6.2.2 2 17 HRS NVD _ _ 2.9  8 / 10 _ _ 16HRS 1HR
3 24 2539 PRIMI 1/28/2012 40 148 52 26.5 _ R 12 4 OD 2.6 1 9. 30 MIN NVD _ _ 2.8  8 / 10 _ _ 7.30MIN 2HRS
4 27 8481 PRIMI 1/27/2012 40+1 158 70 31.1 RH-VE R 7 4 RH-VE 2.4 1 9.15 MIN NVD __ __ 3.3  8 / 10 _ _ 8.15MIN 1HR
5 26 6334 G2P1L1 1/1/2012 40+1 158 56 24.8 10 _ R 9.5 3 PP 2.4 1 4.30 MIN NVD _ PUTEAR 2.9  8 / 10 _ _ 3.15MIN 1.15MIN
6 31 7364 G2P1L0 1/9/2012 40 158 52 23.1
PRE-
ECL R 10 4 OD 2.4 1 9.20 MIN NVD _ _ 2.7  8 / 10 _ 8.15MIN 1.5MIN
7 26 2309 G2A1 2/7/2012 38 157 52 23.1
DM_INS
U R 10.5 3
DM -
INUS
2.7/2.7/
2.6 3 41 HRS LSCS FINDUCTN 2.9  7 / 10 _ _ 41HRS _
8 30 1617
G4P2L2E
1 1/19/2012 40+2 151 49 21.7 9
GEST.H
T R 10 1
GEST.H
T 2.6 1 10.40 MI VACUM _ _ 2.7  7 / 10 _ _ 8.30MIN 2.10MIN
9 23 8273 PRIMI 1/11/2012 39 151 50 22.2 GDM-M R 8 3 GDM-M 2.9 1 13 HRS LSCS MSL _ 2.7  8 / 10 MAS AD 10.30MIN 2.25MIN
10 22 4979 G2P1L1 2/19/2012 40+1 155 56 24.8 2 _ R 8 3 PP 2.6,2.6 2 29.30MIN NVD _ _ 2.7  7 / 10 _ _ 28.45MIN 45MIN
11 28 2651 G2P1L1 3/8/2012 38+6 159 58 25.7 5
ANAEMI
A R 11.8 4 PROM 2.2 1 4.30MIN NVD _ PPH 3.4  8 /10 _ _ 3.30MIN 1HR
12 23 60157 PRIMI 2/26/2012 40+1 160 58 22.6 _ R 9.2 2 PP 3,2.9 2 26.23 MIN LSCS FD PROM 3  6 / 10 MSAF AD 26.23MIN _
13 23 6161 PRIMI 2/10/2012 39+4 156 60 26.6 _ R 4.3 2 OLIGO 3.5,3.5 2 17.46 MIN LSCS FD __ 3  8 / 10 _ _ 17.46MIN _
14 28 1382 PRIMI 3/8/2012 38 159 47 20.8
PRE-
ECL R 9.5 4
PRE_EC
L 2.6,2.2 2 20.12 MIN NVD _ S INJURY 3  8 / 10 _ _ 17.30MIN 2.52MIN
15 32 8636 G2P1L1 2/12/2012 40+2 147 52 26.5 6 _ R 9.8 4 PP
1.8,1.7,
1.7 3 26.40MIN NVD _ _ 2.5  6 / 10 RD AD 25.45MIN 55MIN
16 28 5606 PRIMI 4/11/2012 38 150 58 25.7
GDM-
INS R 9.8 1
GDM-
INS 3.5 1 25.40MIN LSCS CPD _ 3.5  8 /10 _ _ 25.40MIN _
17 23 7364 PRIMI 5/2/2012 34 159 60 26.6
ANAEMI
A R 2 2 PROM 3.3 1 6.15MIN LSCS FD _ 1.72  7 / 10 RDS AD 6.15MIN _
18 23 1779 PRIMI 3/10/2012 40+2 160 60 23.4
ANAEMI
A R 8 2 PP
3,2.9,2.
9 3 46.30MIN LSCS FINDUCTN _ 3.1  8 /10 _ _ 46.30MIN _
19 26 4995 PRIMI 3/22/2012 40+2 138 43 22.6 _ R 9 2 PP 3.1,3.1 2 22 HRS LSCS FINDUCTN _ 2.5  6/ 10 RD AD 22HRS _
20 26 5291 G3P2L1 3/18/2012 39+5 158 52 23.1 2 _ R 5 3 OLIGO 2.6 1 15.38MIN NVD _ _ 3.6  8 /10 _ _ 14HRS 1.38MIN
21 31 6434 PRIMI 3/22/2012 38 146 47 23.9 _ R 7 4 PROM 2.7,2.7 2 15.21MIN LSCS PDECENT _ 2.8  8 / 10 _ _ 11.15MIN 4.6MIN
22 23 3446 PRIMI 3/27/2012 40 152 50 22.2
EPILEPT
IC R 5 4 OLIGO 2.7 1 7.32 MIN LSCS MSL _ 2.7  8 / 10 MSAF AD 6.54MIN 40MIN
23 21 1380 PRIMI 3/14/2012 41 157 55 24.4 _ R 8.4 4 PP 2.6 1 9.45 NVD _ _ 2.5  8 / 10 _ _ 7HRS 2.45MIN
24 29 8007
G3P1LIA
1 3/8/2012 40+1 153 60 26.6 2 _ R 10 3 PP 2.4 1 5.43 MIN NVD _ _ 3  8 / 10 _ _ 4.30MIN 1.13MIN
25 29 7129
G3P1LIA
1 3/12/2012 39+5 140 56 28.5 5
GEST.H
T R 8 4
GEST.H
T 2.6 1 13.25 MIN NVD _ _ 2.5  7 / 10 _ _ 12.15MIN 1.10MIN
26 27 4384 G2P1L1 4/12/2012 39 152 52 23.1 3
PRE-
ECL R 12 4
PRE_EC
L 2.4 1 6.38 MIN NVD _ PPH 2.6  8 / 10 _ _ 5HRS 1.38MIN
27 26 40460 PRIMI 4/17/2012 37+5 156 60 26.6 _ R 6 1 PROM 3.4 1 7.8 MIN LSCS FD _ 2.8  8 / 10 RD AD 7.8MIN _
28 30 5774 PRIMI 4/5/2012 39+5 146 47 23.9 GDM-M R 8 4 GDM-M 2.4 1 10.11MIN NVD _ _ 3  8 / 10 _ _ 6.45MIN 3.26MIN
29 24 8610 G2P1L1 4/8/2012 40+4 153 49 21.7 3 _ R 11 4 PP 2 1 2.45 MIN NVD _ _ 2.7  7 / 10 _ _ 2HRS 45MIN
30 28 30730 PRIMI 4/26/2012 38+2 157 60 26.6
PRE-
ECL R 7 2
PRE_EC
L 2.9 1 6.22 MIN LSCS PRE-ECL PPH 3  8 / 10 _ _ 6.22MIN
31 33 7584 G2P1L0 5/23/2012 40 149 56 28.5 _ R 8 3 OD 2.6,2.5 2 14.35 MIN NVD _ _ 3.2  8 /10 _ _ 12.35MIN 2HRS
32 24 8958 PRIMI 5/20/2012 41+1 150 50 22.5 _ R 9 4 PP 2.4 1 8.38 MIN NVD _ _ 2.75  7 /10 _ _ 7.30MIN 1.8MIN
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33 24 2641 G2P1L1 4/10/2012 41+1 153 52 23.7 3
ANAEMI
A R 10 4 PP 2.6 1 8.55 MIN FORCEPS _ _ 2.85  8 /10 RD AD 7.30MIN 1.25MIN
34 26 5289 G2A1 5/21/2012 38+4 155 60 26.6 _ R 5 3 OLIGO 2.7 1 6.20 MIN LSCS FD _ 2.75  8 / 10 TTN AD 6.20MIN _
35 23 1329 G2A1 5/12/2012 39+3 159 61 27.1 _ R 4.5 3 OLIGO 2.7,2.7 2 15.30 MIN LSCS FINDUCTN _ 2.61  7 /10 _ _ 15.30MIN _
36 28 7177
G4P1L1A
2 5/29/2012 38+2 154 51 22.6 5
GDM-
INS R 8.8 4
GDM-
INS 2.6 1 7.31 MIN NVD _ _ 3.25  7 /10 _ _ 7HRS 31MIN
37 25 1139 G3P2L1 5/21/2012 39+5 157 54 24 6
PRE-
ECL R 10.5 1
PRE_EC
L
2.9,2.9.
2.8 3 55.25 MIN LSCS FINDUCTN _ 2.4  8/10 _ _ 55.25MIN _
38 32 30485 PRIMI 5/27/2012 38+4 148 53 27 DM-INS R 12 2 DM-INS 3.3,3.3 2 23.45 MIN LSCS FINDUCTN _ 2.7  8 / 10 _ _ 23.45MIN _
39 22 3249 G2A1 5/9/2012 40 157 58 25.7 _ R 7 4 OD 2.7,2.7 2 23.25 MIN LSCS NONPROG _ 3.5  8 / 10 _ _ 22.25MIN 1.10MIN
40 27 NGO PRIMI 5/17/2012 39 152 58 25.7 GDM-M R 8 3 GDM-M 2.7 1 10  HRS LSCS FVENTOSE PPH 3.4  8 /10 _ 7HRS 3HRS
41 27 7381 G2P1L1 6/13/2012 40+2 155 52 23.1 7 _ R 5 1 OLIGO 3.2 3 24.12 MIN LSCS FINDUCTN _ 2.75  7 /10 _ _- 24.12MIN _
42 23 4171 PRIMI 1/30/2012 40+1 149 56 28.5 _ R 8 2 PP 3,2.9 2 14.53MIN LSCS FD _ 3.7  8 / 10 _ _ 14.53MIN _
43 26 2673 G2P1L1 1/17/2013 40+1 156 52 23.1 3 _ R 7 4 PP 2.6 1 12.20MIN NVD _ _ 3.1  8 / 10 _ _ 11HRS 1.20MIN
44 22 4693 PRIMI 2/12/2013 40+1 149 59 30 _ R 8 0 PP
3.3,3.3,
3.3 3 41HRS LSCS FINDUCTN _ 3.7  8 / 10 _ _ 41HRS _
45 26 2744 G2P1L1 2/13/2013 40 160 58 23.2 2 _ R 8.2 4 OD 2.4 1 9HRS NVD _ _ 3.1  8 / 10 _ _ 7HRS 2HRS
46 22 2748 G2A1 2/12/2013 39 159 51 22.6
PRE-
ECL R 8.5 3
PRE_EC
L 2.6 1 12HRS NVD _ _ 2.8  8 / 10 _ _ 10HRS 2HRS
47 24 2679
G3P1L1A
1 2/25/2013 38 160 60 26.5 2
GDM-
INS R 9 4
GDMIN
S 2.6 1 14HRS NVD _ _ 3  8 / 10 _ _ 12HRS 2HRS
48 22 6514 PRIMI 7/18/2012 40+1 159 56 24.5 _ R 7 4 PP 2.6 1 17.36MIN FORCEPS _ CPT 2.7  7 / 10 _ _ 10.35MIN 7.1MIN
49 27 6127 G2A1 7/17/2012 40 153 53 23.5
ANAEMI
A R 9 3 OD
2.6,2.4,
2.4 3 29.5 MIN NVD _ _ 2.75  8 /10 _ _ 26.15MIN 2.50MIN
50 25 5409 PRIMI 7/18/2012 40 153 62 27.5 _ R 7 1 OD 3.1,3,3 3 24HRS LSCS FINDUCTN _ 3.3  8 /10
HYDR
OCEPH
ALUS 24HRS _
51 28 2563 PRIMI 7/17/2012 39+2 150 53 23.5 GDMINS R 8 3
GDM-
INS
2.6,2.5,
2.5 3 36.40MIN VACUM _ _ 3  8 /10 _ _ 34.20MIN 2.20MIN
52 26 7391 PRIMI 7/26/2012 40+4 153 62 27.5 R 10 4 PP 2.6 1 10.3MIN VACUM _ PPH 3.07  8 /10 _ _ 5HRS 5.30MIN
53 24 4495 PRIMI 8/3/2012 38 152 46 20.4 _ R 7 3 PROM 2.6,2.5 2 17HRS NVD _ _ 2.65  7 /10 _ _ 14HRS 3HRS
54 23 6826 PRIMI 8/23/2012 40 160 59 23.4 RH-VE R 7.6 4 RH -VE 2.6 1 14.10MIN FORCEPS _ _ 2.7  8 /10 _ _ 12HRS 2.10MIN
55 29 8822 PRIMI 9/1/2012 40+2 154 59 26.2 GDM-M R 9 0 PP
3.4,3.3,
3.3 3 32.20MIN LSCS FINDUCTN _ 2.8  8 /10 _ _ 32.20MIN _
56 28 20910 G2A1 9/6/2012 40+1 149 47 23.9 _ R 9 4 PP
2.7,2.7,
2.7 3 46.30MIN LSCS FINDUCTN _ 3.6  8 /10 MSAF _ 46.30MIN _
57 28 4045 PRIMI 9/21/2012 38 151 60 26.6 _ R 4 0 OLIGO
3.1,3,2.
9 3 48HRS LSCS FINDUCTN _ 3.2  8/10 _ _ 48HRS
58 26 3110 PRIMI 9/27/2012 40+1 155 59 26.8 _ R 8 2 PP 2.6,2.4 2 21.45MIN NVD _ _ 3  8 /10 _ _ 17HRS 4.45MIN
59 32 6613
G3P1LIA
1 9/25/2012 39+4 147 53 27.4 3
PRE-
ECL R 8 3
PRE_EC
L 2.6,2.6 2 13HRS NVD _ _ 3.1  8 /10 _ _ 10HRS 3HRS
60 26 1292 PRIMI 9/27/2012 38+4 149 45 22.9 _ R 8 4 PROM 2 1 5 HRS NVD _ _ 2.8  8/10 _ _ 4HRS 1HR
61 23 1719 G2P1L1 9/21/2012 39+5 157 54 24 2
PRE-
ECL R 8 4
PRE_EC
L 2.6,2.6 2 33.49MIN NVD _ PPH 2.9  8 /10 _ _ 31HRS 2.49MIN
62 24 4707 PRIMI 10/12/2012 39+3 158 56 24.8
HYPOT
HY R 8 4 GDM-M 2.4,2.3 2 29.10MIN NVD _ _ 3.3  8 /10 _ _ 25HRS 4.10MIN
63 28 1177 PRIMI 10/23/2012 40+3 153 60 26 _ R 7 2 PP
3,2.9,2.
8 3 25.40MIN LSCS FINDUCTN _ 3.2  7 /10 MSAF _ 24HRS 1.45MIN
64 24 8270 PRIMI 10/17/2012 40+3 159 55 24.4 _ R 7.7 1 PP 3 2 33.8 MIN LSCS FINDUCTN _ 3.3  8 /10 _ _ 33.8MIN _
65 27 2449 G2P1L1 11/1/2012 40+3 159 56 24.8 2 _ R 9.5 4 PP 2.6 1 6 HRS NVD _ _ 3  8 /10 _ _ 4HRS 2HRS
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66 27 9809 G2A1 12/8/2012 40 160 55 21.4 _ R  1 1 1 OD 2.7 2 23 HRS LSCS FD _ 3.6  8/10 _ _ 21HRS 2HRS
67 22 2035 G2A1 1/9/2012 39+5 150 53 23.5
GEST.H
T R 8.7 4
GEST.H
T 2.7 2 20.20 MIN LSCS FD _ 2.8  6 /10 MSAF AD 18.30MIN 1.50MIN
68 22 2223 PRIMI 12/5/2012 39 149 46 23.4
ANAEMI
A R 10 2 GDM-M 3 1 28.40MIN LSCS FD _ 2.75  8 /10 _ _ 28.40MIN _
69 32 609 PRIMI 1/26/2013 39+5 156 59 26.2 GDM-M R 11 3 GDM_M 2.8 1 5.32MIN LSCS PPREVIA _ 3.4  8 /10 _ _ 5.32MIN _
70 23 3109 PRIMI 1/4/2013 40 160 68 26.5
HYPOT
HY R 9 4 OD 2.6,2.6 2 13.10MIN NVD _
MAN R OF
PLACENTA 2.7  8 /10 _ _ 11.45MIN 1.25MIN
71 25 1479 PRIMI 3/4/2013 40 143 64 32.6
ANAEMI
A R 8 3 OD 2.9 1 11.40MIN LSCS FD _ 3.3  7 / 10 _ _ 10.26MIN 1.14MIN
72 26 3333 G2P1L1 2/20/2013 39+3 157 56 24.8 4 _ R 5 4 PROM 2.4 1 5.30MIN NVD _ _ 2.7  8 / 10 _ _ 4.40MIN 40MIN
73 22 8555 PRIMI 3/9/2013 38+2 156 63 28
HYPOT
HY R 7 2 IUGR 2.9,2.9 2 32.30MIN LSCS FD _ 2.4  7 / 10 IUGR RD 32.30MIN _
74 20 9957 PRIMI 3/21/2013 40+1 161 63 24.6 _ R 9 3 PP 2.8,2.7 2 29.15MIN LSCS FD _ 3.4  8/10 MSAF _ 26.15MIN 3.30MIN
75 24 40870 PRIMI 3/7/2013 40 150 53 23.5 _ R 11 2 OD 3.2 1 6.30MIN LSCS FD _ 3  8 / 10 _ _ 6.25MIN _
76 21 2627 PRIMI 3/1/2013 40+4 157 60 26.6 _ R 8 3 PP 2.8,2.9 2 11.30MIN LSCS FD _ 3  8 / 10 _ _ 11.30MIN _
77 26 5580 PRIMI 3/13/2013 40 152 76 33.6
GEST.H
T R 8 2
GEST.H
T
2.6,2.6,
2.2 3 72HRS NVD _
MAN R OF
PLACENTA 2.7  8 / 10 _ _ 69HRS 3HRS
78 24 2455 PRIMI 3/3/2013 40+4 146 56 28.5 HBSAG+ R 8 2 PP 3.1,3,3 3 48.14MIN LSCS FINDUCTN _ 2.9  8 / 10 _ AD 48.14MIN _
79 32 7387 PRIMI 3/23/2013 40 158 60 26.6 _ R 10 1 OD
3.2,3.1,
3.1 3 48.30MIN LSCS FINDUCTN _ 3.3  7 / 10 TTN _ 48.30MIN _
80 22 3718 PRIMI 3/7/2013 40+1 160 62 24.4 _ R 9 4 PP 2.5,2.4 2 26HRS NVD _ _ 2.9  7 /10 _ _ 25HRS 1HR
81 26 8565 PRIMI 3/26/2013 40+1 148 60 30.6 _ R 8 2 PP 2.9 1 7.45MIN LSCS FD _ 2.8  8 / 10 MSAF _ 7.45MIN _
82 23 2031 PRIMI 3/3/2013 40+3 156 60 26.6 _ R 11 2 PP 2.6,2.5 2 18.50MIN VACUM _ _ 3  8 /10 HIE HIE 17HRS 1.50MIN
83 30 8044 PRIMI 4/26/2012 40+1 156 60 26.6 _ R 12 1 PP
3.2,3.2,
3.2 3 48.14MIN LSCS FINDUCTN PPH 3.6  8 / 10 _ _ 48.14MIN _
84 29 8747 PRIMI 5/6/2013 40 156 53 23.5 _ R 6 2 OD 2.6,2.5 3 25.15MIN FORCEPS _ _ 2.8  8 / 10 RD _ 17.30MIN 7.45MIN
85 27 8167 PRIMI 5/27/2013 37+5 144 45 22.9 _ R 7 4 PROM 2.6 1 4.15MIN VACUM _ __ 2.7  8 / 10 _ _ 2HRS 2.15MIN
86 23 5293 PRIMI 5/15/2013 41+1 159 49 21.7 _ R 7 3 PP 2.4 1 10.32MIN NVD _ _ 2.6  8 /10 _ _ 9.45MIN 47MIN
87 24 10036 PRIMI 6/5/2013 38 154 59 26.6
PRE-
ECL R 16 2
PRE_EC
L
3.2,2.9,
2.9 3 46.15MIN LSCS FINDUCTN _ 3.2  7 / 10 _ _ 46.15MIN _
88 28 5572
G4P1L1A
2 5/27/2013 39+2 156 52 23.1 2 GDM-M R 6 2 GDM-M 2.2 1 12.10MIN NVD _ _ 3.3  8 / 10 _ _ 9.30MIN 2.40MIN
89 26 5679 G3P2L2 5/21/2013 39+6 159 53 23.5 3 GDM-M R 8 4 GDM-M 2.6,2.6 2 16.30MIN NVD _ _ 2.9  8 / 10 _ _ 14.30MIN 2HRS
90 30 8699 PRIMI 5/23/2013 39+5 153 57 25.3
GEST.H
T R 8 0
GEST.H
T
3.2,3.1,
3.1 3 72HRS LSCS FINDUCTN _ 3.4  8 / 10 MSAF _ 72HRS _
91 29 8797 PRIMI 5/25/2013 39+3 144 56 28.5 _ R 9 3 PROM 2.8,2.7 2 20.50MIN LSCS FD _ 2.9  9 / 10 _ _ 20.50MIN _
92 28 9094 PRIMI 5/23/2013 37+5 155 58 25.7 _ R 10 1 PROM
2.6,2.5,
2.5 3 46.51MIN VACUM _ _ 3  7 / 10 _ _ 44MIN 2.51MIN
93 34 3064 PRIMI 5/25/2013 38+5 157 59 26.2
PRE-
ECL R 6 3
PRE_EC
L 2.9 1 9.45MIN LSCS FD _ 3.5  8 / 10 _ _ 9.45MIN _
94 25 8489 G2A1 5/1/2013 40+4 152 53 23.5 _ R 9 4 PP 3 1 8HRS LSCS FD _ 2.5  7 / 10 MSAF _ 8HRS _
95 24 8851 PRIMI 5/10/2013 38+6 158 49 21.7 _ R 6 4 OLIGO 2.4 1 3.56MIN VACUM _ _ 2.6  7 / 10 _ _ 3HRS 56MIN
96 28 6621 PRIMI 5/21/2013 40 146 82 41.8 GDM-M R 9 2 GDM-M
3.3,3.3,
3.3 3 72HRS LSCS FINDUCTN _ 3.7  7 / 10 _ _ 72HRS _
97 26 6717 G2A1 8/22/2013 38 153 49 21.7 _ R 4 3 OLIGO 2 1 9.52MIN NVD _ _ 2.5  8 / 10 _ _ 7HRS 2.52MIN
98 22 5378 PRIMI 5/25/2013 40 152 68 30.2 RH-VE R 6 2 RH-VE 3.1,3,3 3 73.11MIN LSCS FINDUCTN _ 2.5  8 / 10 _ _ 72.11MIN _
99 24 5342 G2P1L1 5/24/2013 40+1 151 55 24.4 4 RH-VE R 7 4 RH-VE 2.4 1 8.15MIN NVD _ _ 2.8  9 / 10 _ _ 6HRS 2.15MIN
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100 24 6398 PRIMI 6/12/2013 39+5 160 70 28
HYPOT
HY R 6 4 OLIGO 2.4 1 6.46MIN VACUM _ _ 2.5  8 / 10 MSAF _ 5.10MIN 1.36MIN
101 28 3410 PRIMI 6 / 7/2013 38+6 156 59 26.2 _ R 7 3 PROM 3 1 18HRS LSCS FD _ 3.2  8 /10 _ _ 18HRS _
102 24 8719 PRIMI 6/27/2013 39+1 152 72 32 _ R 9 3 PROM 2.7,2.7 2 15.47MIN LSCS FINDUCTN _ 3  8 / 10 IUGR AD 15.47MIN
103 30 3798 PRIMI 6/22/2013 39+6 150 64 28.4 _ R 5 2 OLIGO 3,3,3 3 47.25MIN LSCS FINDUCTN _ 3.2  8 / 10 RD _ 47.25MIN _
104 25 1720 PRIMI 6/8/2013 40 156 78 34.6 _ R 5 3 OLIGO 2.6,2.5 2 24.20MIN NVD _ _ 2.5  8 / 10 _ _ 23HRS 1.20MIN
105 23 50955 PRIMI 25 / 6/2013 40+1 151 54 24 _ R 7 1 PP
3.2,3.1,
3.1 3 17HRS LSCS FD _ 4  8 / 10 RD AD 16HRS 1HR
106 26 3753 PRIMI 6/30/2013 39+5 145 49 25
HYPOT
HY R 4 3 PROM 2.8,2.8 2 10.18MIN LSCS FD _ 3.1  8 / 10 _ _ 10.18MIN _
107 23 9254 PRIMI 7/17/2013 36+3 152 60 26.6 _ R 7 2 PROM 3.2 1 15.10MIN LSCS FD _ 2.8  8 / 10
PERIN
ATAL
HYPO
XIA 15.15MIN _
108 23 1284 PRIMI 6/26/2013 40+1 159 50 22.2 _ R 8 3 PP
2.6,2.6,
2.5 3 31.20MIN NVD _ _ 3.3  8 / 10 _ _ 28HRS 3.20MIN
109 24 9043 PRIMI 6/17/2013 40 157 49 21.2 _ R 7 4 OD 2.6 1 7.21MIN NVD _ _ 2.9  8 / 10 _ _ 6HRS 1.21MIN
110 24 2396 G2P1L1 6/11/2013 40 158 51 22.6 2 _ R 9 4 OD 2.4 1 10HRS VACUM _ _ 2.5  8 / 10 IUGR AD 8.30MIN 1.30MIN
111 22 90882 PRIMI 6/6/2013 40 156 62 27.5 _ R 6 3 OD 2.6,2.5 2 32.25MIN FORCEPS _ _ 2.9  7 / 10 _ _ 28.15MIN 4.10MIN
112 19 40496 PRIMI 6/20/2013 40+1 156 60 26.6 _ R 9 4 PP 2.6,2.6 2 21.30MIN VACUM _ _ 3.35  8 / 10 _ _ 19HRS 2.30MIN
113 26 7071 G2P1L1 6/17/2013 39+6 153 60 26.6 8 _ R 12 3 PROM 2.9 1 19.38MIN LSCS FD _ 3.4  8 / 10 MSAF _ 19.38MIN _
114 25 8881 PRIMI 6/1/2013 39+6 156 59 26.2
GEST.H
T R 7 2
GEST.H
T 2.9 1 17.15MIN LSCS FD _ 3.4  8 / 10 _ _ 17.15MIN _
115 21 1962 PRIMI 6/27/2013 39 152 60 26.6 _ R 6 2 PROM 3 1 6HRS LSCS FINDUCTN _ 2.4  8 / 10 FD _ 6HRS _
116 20 8626 PRIMI 7/11/2013 40+1 159 60 26.6 _ R 9 1 PP
3.2,3.1,
3.1 3 51.31MIN LSCS FD _ 3.2  8 / 10 MSAF AD 51.35MIN _
117 25 5063 PRIMI 6/28/2013 38 158 63 28
GDM-
INS R 12 1
GDMIN
S 3.1,3.1 2 18.41MIN LSCS FD _ 2.9  8 / 10 IDM AD 18.14MIN _
118 35 8741
G4P1L0A
2 6/12/2013 39+5 157 70 31.1 GDM-M R 11 3 GDM-M 2.6,2.4 2 15.40MIN NVD _ _ 3.3  7 / 10 _ _ 14HRS 1.40MIN
119 35 9476
G4P1L1A
2 7/8/2013 38+1 152 64 28.4 10
GDM-
INS R 9 4
GDMIN
S
2.6,2.6,
2.5 3 25HRS NVD _ _ 2.8  8 / 10 _ _ 24HRS 1HR
120 22 1383
G3P1LIA
1 6/13/2013 40+1 156 60 26 3 _ R 8 4 PP 2.3 1 8 HRS NVD _ _ 3  8 / 10 _ _ 7.35MIN 25MIN
121 22 3107 G2P1L1 7/5/2013 40 151 47 20.6 2 _ R 10 3 OD 2.4 1 8.55MIN NVD _ _ 2.9  8 / 10 _ _ 8.30MIN 25MIN
122 19 4059 PRIMI 7/16/2013 40 154 67 29.7 _ R 9 3 OD 2.6,2.5 2 21.23MIN NVD _ _ 2.9  8 / 10 _ _ 20.10MIN 1.1MIN
123 20 8626 PRIMI 7/11/2013 40+1 152 59 26.2
ANAEMI
A R 9 1 PP
3.2,3.1,
3.1 3 50.30MIN LSCS FINDUCTN _ 3.2  8 / 10 RD AD 50.30MIN _
124 28 5138 PRIMI 7/22/2013 39+3 169 99 30.52 GDM-M R 11 1 GDM-M
3.2,3.2,
3.2 3 34.53MIN LSCS FINDUCTN _ 3.2  8 / 10 _ _ 34.53MIN _
125 22 5648 PRIMI 7/22/2013 39+2 153 49 21.7 _ R 7 3 OLIGO 2.6 1 18HRS NVD _ _ 2.8  8 / 10 _ _ 14HRS 4HRS
126 27 8997 PRIMI 7/27/2013 38+1 152 55 21.6 _ R 8 4 PROM 2.4 1 8HRS NVD _ _ 3  8 / 10 _ _ 6.20MIN 1.40MIN
127 25 5108 PRIMI 7/26/2013 38+3 165 52 20 HBSAG+ R 5 4 OLIGO 2.3 1 8.40MIN NVD _ _ 2.8  8 / 10 _ 6.30MIN 2.10MIN
128 18 7765 PRIMI 7/17/2013 39+3 144 40 18.2 _ R 9 4 PROM 2.4 1 11.8MIN NVD _ _ 2.4  8 / 10 _ _ 9.30MIN 1.38MIN
129 28 8868 G2P1L1 7/13/2013 38+6 149 51 22.9 2 GDM-M R 7 4 GDM-M 2.6 1 6.45MIN NVD _ _ 2.7  8 / 10 6.30MIN 15MIN
130 24 6456 PRIMI 7/19/2013 40+1 157 64 28.4 _ R 9 4 PP 2.6,2.5 2 23.25 NVD _ _ 3.2  8 / 10 _ _ 18.35MIN 4.50MIN
131 20 2253 PRIMI 7/27/2013 39 153 62 26.4
PRE-
ECL R 8 4
PRE_EC
L 2.6,2.5 2 12.10MIN NVD _ _ 2.4  8 / 10 IUGR AD 11HRS 1.15MIN
132 28 80893 PRIMI 7/18/2013 40 158 72 28.9 _ R 11.8 3 OD 2.6 1 8.45 FORCEPS _ _ 2.8  8 / 10 MSAF AD 8HRS 46MIN
133 26 2573 G2P1L1 7/22/2013 39+5 163 54 21 3 _ R 4 3 OLIGO 2.6,2.5 2 15.26MIN NVD _ _ 3  8 / 10 _ _ 12HRS 3.26MIN
134 27 5399 PRIMI 7/26/2013 40+1 166 66 19 _ R 3 3 OD 2.6,2.5 2 13.3MIN NVD _ _ 2.9  8 / 10 _ _ 11.15MIN 1.48MIN
135 27 8644 PRIMI 8/1/2013 39+6 154 53 23.5 _ R 6 3 OLIGO 2.6 1 18.50MIN NVD _ _ 2.6  8 / 10 MSAF AD 16HRS 2.50MIN
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136 29 20117 PRIMI 7/24/2013 40 163 65 25.9 _ R 7 3 OD 2.5 1 26HRS VACUM _ _ 3.2  8 / 10 HIE AD 22.45MIN 3.15MIN
137 27 6645 PRIMI 9/19/2013 38+3 148 51 26
GDM-
INS R 12 4
GDMIN
S 2.6 1 10HRS NVD _ _ 2.8  8 / 10 IDM AD 8HRS 2HRS
138 33 7012 PRIMI 8/22/2013 40 156 70 28.6 GDM-NS R 10 1
GDMIN
S 3.1,3 2 46.10MIN LSCS FD _ 3.3  8 / 10 IDM AD 46.10MIN _
139 21 7044 PRIMI 8/21/2013 40+1 150 49 21.7 _ R 12 3 PP 2.8 1 7HRS LSCS FD _ 3.2  8 / 10 HIE AD 7HRS _
140 27 5053 G2A1 8/12/2013 39+3 150 70 27.5
GEST.H
T R 12 3
GEST.H
T 2.7 1 8.16MIN LSCS FD PPH 3.7  8 / 10 _ _ 6.15MIN 2.1MIN
141 23 9282 PRIMI 8/20/2013 40+1 152 45 20 _ R 9 3 PP 2.6,2.5 2 20.5MIN NVD _ _ 2.9  8 / 10 _ _ 18HRS 2.5MIN
142 21 3138 PRIMI 8/13/2013 39+2 161 61 19.3 GDM-M R 8.8 4 GDM_M 2.5,2.4 2 11.30MIN NVD _ MROP 3.4  8 / 10 _ 10HRS 1.30MIN
143 26 2502 PRIMI 8/16/2013 40+1 149 55 22.52 _ R 8 3 PP 2.6,2.6 2 26.41MIN NVD _ _ 3  8 / 10 _ _ 24HRS 2.41MIN
144 26 2919
G3P1LIA
1 8/21/2013 38 161 71 27.7 3
GDM-
INS R 9.5 4
GDMIN
S 2.2 1 7HRS NVD _ _ 3.1  7 /   10 _ _ 6.45MIN 15MIN
145 25 1812 PRIMI 9/4/2013 40 151 52 23.1 _ R 8.8 2 PP 2.6,2.5 2 30.37MIN FORCEPS _ _ 2.4  7 / 10 IUGR AD 26.30MIN 4.7MIN
146 24 5829
G3P1LIA
1 9/15/2013 40+2 164 64 25 _ R 9 3 PP 2.4 1 9.15MIN NVD _ _ 2.7  8 / 10 MSAF AD 8HRS 1.15MIN
147 24 7357 G3A2 9/12/2013 40 153 48 21.3 _ R 6 4 OD 2.5,2. 2 22.10MIN VACUM _ _ 3.1  7 / 10 _ _ 19.30MIN 2.40MIN
148 28 8768 PRIMI 9/17/2013 38 155 52 23.1
GDM-
INS R 10 3
GDMIN
S 2.6,2.5 2 20.30MIN VACUM _ PPH 2.7  8 / 10 _ _ 16.3OMIN 4HRS
149 29 1506 PRIMI 9/15/2013 39+4 150 54 24 _ R 5 3 OLIGO 2.7,2.6 2 19.10MIN LSCS FD _ 2.8  6 / 10 MSAF AD 18HRS 55MIN
150 24 6984 G2P1L1 9/21/2013 40+3 154 45 20 _ R 8 3 PP 2.6,2.4 2 11.30MIN NVD _ _ 3.2  8 / 10 _ _ 9HRS 2.30MIN
151 28 8319 PRIMI 10/1/2013 39+3 149 46 23.4 GDM-M R 7.5 4 GDM-M 2 1 8HRS NVD _ _ 3  8 / 10 IDM AD 6.50MIN 1.15MIN
152 26 6372 PRIMI 10/12/2013 38 153 71 31.5 _ R 8.6 2 PROM 2.9,2.7 2 13.10MIN LSCS FD _ 2.8  8 / 10 _ _ 13.10MIN _
153 21 4528 PRIMI 9/29/2013 38+5 154 54 24 GDM-M R 7.4 4 GDM-M 2.6 1 5.14MIN NVD _ _ 2.8  8 / 10 _ _ 4HRS 1.14MIN
154 22 7363 PRIMI 9/27/2013 40 147 45 20.8 _ R 8 4 OD
2.8,2.8,
2.8 3 36.30MIN LSCS FINDUCTN _ 3.7  8 / 10 _ _ 36.30MIN _
155 24 2550 PRIMI 10/1/2013 40 160 65 25 _ R 8 4 OD 2.6 1 14.20MIN VACUM _ _ 3.2  8 / 10 _ _ 11HRS 3.20MIN
156 26 6628 G2P1L1 10/27/2013 40+2 164 63 24.6
SCTRAI
T R 16 4 PP 2.4 1 14.45MIN NVD _ _ 3.7   8 / 10 MSAF _ 13HRS 1.45MIN
157 26 9693 PRIMI 10/13/2013 40 166 59 23 _ R 8 1 OD 2.6 1 14.22MIN NVD _ _ 3.1  8 / 10 _ _ 13HRS 1.22MIN
158 24 3083 PRIMI 10/29/2013 38+3 154 60 26.6
GDM-
INS R 9.8 0
GDMIN
S
3.3,3.3,
3.3 3 26HRS LSCS FINDUCTN _ 3.6  8 / 10 IDM AD 26HRS _
159 29 6937 PRIMI 17/10/20133 40+1 149 45 22.9 _ R 12 3 PP 2.7 1 12.30MIN LSCS FD _ 3  8 / 10 TTN AD 12.30MIN _
160 32 100851 PRIMI 11/2/2013 38+4 159 60 26.6
PRE-
ECL R 3.5 0 OLIGO
3.5,3.5,
3.5 3 19.15MIN LSCS FINDUCTN _ 2.4  8 / 10 RD AD 19.15MIN _
161 20 2725 G2A1 10/18/2013 40 156 54 24
ANAEMI
A R 12 2 OD
2.6,2.5,
2.5 2 22.19MIN NVD _ _ 2.7  8 / 10 _ _ 20HRS 2.19MIN
162 24 1175 PRIMI 11/3/2013 38 159 40 17.7 _ R 4.5 2 OLIGO
3.1,3.1,
3.1 3 23.45MIN LSCS FINDUCTN _ 2.6  8 / 10 _ _ 23.45MIN _
163 29 5533 PRIMI 10/12/2013 40+1 162 59 23 _ R 6 2 PP 2 2 11.5MIN NVD _ _ 2.7  8 / 10 _ _ 10HRS 1.5MIN
164 30 3906 G2P1L1 10/21/2013 38+6 158 53 23.5 _ R 8.9 2 PROM 2.6,2.4 2 11HRS NVD _ _ 2.9  8 / 10 _ _ 9.30MIN 1.30MIN
165 35 1225 PRIMI 9/17/2013 39+1 158 102 45.3
GEST.H
T R 12 3
GEST.H
T 2.8 1 3.30MIN LSCS FD _ 2.5  8 / 10 _ _ 3.30MIN _
166 25 2978 PRIMI 10/18/2013 39+6 169 52 20.3 _ R 10 3 PROM 2.7 1 18HRS LSCS PDECENT _ 3.4  8 / 10 _ _ 14HRS 4HRS
167 25 3156
G3P1L1A
1 10/14/2013  40+1 157 51 22.6 3 _ R 7 3 PP 2.1 1 2.30MIN NVD _ _ 3.2  8 / 10 _ _ 1.50MIN 40MIN
168 26 500583 PRIMI 10/10/2013 40 153 46 20.4 _ R 4.5 2 OLIGO
3.2,3.1,
3.1 3 29.30MIN LSCS FINDUCTN _ 3.1  8 / 10 _ _ 29.30MIN _
169 25 3020
G4P1L1A
1 10/13/2013 38+5 149 40 20.4 2 _ R 4 4 OLIGO 2 1 2.11MIN NVD _ _ 1.9  7 / 10 IUGR AD 1.40MIN 31MIN
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170 30 2144 PRIMI 10/8/2013 39+3 145 42 21.4 GDM-M R 9 2 GDM-M
3,2.9,2.
9 3 24HRS LSCS FINDUCTN _ 2.8  8 / 10 _ _ 24HRS _
171 22 7451 PRIMI 10/27/2013 37+1 164 54 21.6 _ R 2 0 PROM 3.1,3.1 2 12HRS LSCS FD _ 2.4  8 / 10 IUGR AD 12HRS _
172 26 8498 PRIMI 10/31/2013 39 158 49 21.7 _ R 9 4 PROM 2.2 1 3.29MIN NVD _ PPH 2.4  8 / 10 _ _ 3.10MIN 19MIN
173 26 90578 PRIMI 10/12/2013 39+2 152 40 17.7 GDM-M R 8 2 GDM-M 2.6,2.5 2 19.25MIN VACUM _ _ 3  8 / 10 RD AD 15HRS 3.45MIN
174 31 9201
G4P2L2A
1 10/26/2013 39+3 158 49 21.7 2 _ R 5 3 OLIGO 2.6,2.5 2 25.43MIN NVD _ _ 2.5  8 / 10 _ _ 24HRS 1.43MIN
175 26 900370 PRIMI 10/27/2013 40+1 148 48 24.4 _ R 11 2 PP 2.7 1 13HRS FORCEPS _ _ 2.7  8 / 10 RDS AD 11HRS 2HRS
176 24 8291 PRIMI 11/5/2013 38+6 154 51 22.6 _ R 5 4 OLIGO 2.7,2.6 2 27.10MIN LSCS NPL _ 2.5   8 / 10 _ _ 27.10MIN _
177 32 2152 G2P1L0 10/27/2013 40+1 145 46 23.4 _ R 9.8 4 PP 2.6,2.4 2 25.42MIN NVD _ _ 2.8  8 / 10 MSAF AD 24.12MIN 1.30MIN
178 21 8825 PRIMI 11/18/2013 37 144 49 25 _ R 6 4 OLIGO 2.7 1 9.15MIN LSCS FD _ 2.3  8 / 10 LBW AD 9.15MIN _
179 27 4270 G2P1L1 10/27/2013 40+1 153 63 28 3 _ R 8.4 3 PP 2.5 1 6.10MIN NVD _ _ 2.7  8 / 10 _ _ 5HRS 1.10MIN
180 27 1613
G3P1LIA
1 10/22/2013 40+2 153 50 22.2 2 _ R 15 4 PP 2.6 1 8HRS NVD _ SDYSTOCIA 3.8  8 / 10 IDM AD 7HRS 1HR
181 26 2479 PRIMI 10/30/2013 40 150 65 28.8 _ R 4.5 2 PROM
3.2,3.1,
3.1 3 23HRS LSCS FINDUCTN _ 3.1  8 / 10 _ _ 23HRS _
182 25 9853 PRIMI 11/15/2013 38+2 155 51 22.6 _ R 6 4 PROM 2.4 1 8.15MIN NVD _ _ 2.7  8 / 10 _ _ 7HRS 1.15MIN
183 23 7897 G2P1L0 11/5/2013 39+3 156 49 21.7 _ R 5 3 OLIGO 2.7 1 10.50MIN VACUM _ _ 2.7  8 / 10 _ _ 9HRS 2.50MIN
184 30 2532 PRIMI 11/9/2013 38+3 169 82 32.03
GDM-
INS R 9 4
GDMIN
S
2.7,2.7,
2.7 3 55HRS LSCS FD _ 3.9  8 / 10 IDM AD 55HRS _
185 24 7474
G3P1L0A
1 11/11/2013 40 158 56 24.8 _ R 6 2 OD
3.5,3.4,
3.4 3 23.45MIN LSCS FINDUCTN _ 3.2  7 / 10 _ _ 23.45MIN
186 32 4517
G3P1L1A
1 10/28/2013 40+1 162 65 25.3 10 _ R 14 3 PP 2.7,2.7 2 19.15MIN LSCS FD _ 3.1  8 / 10 MSAF AD 19HRS _
187 30 1622 PRIMI 11/23/2013 38+4 159 60 26.6
PRE-
ECL R 11 1
PRE_EC
L
3.2,3.1,
3.1 3 53.45MIN LSCS FINDUCTN _ 2.6  8 / 10 IUGR AD 53.45MIN _
188 21 2397 PRIMI 11/15/2013 40+2 155 53 23.5 _ R 7 4 PP 2.6.2.2 2 20HRS FORCEPS FD _ 3  8 / 10 _ _ 16HRS 14HRS
189 22 1360 PRIMI 11/6/2013 38+6 150 59 26.2
GDM-
INS R 13 3
GDMIN
S 2.7 1 9.50MIN LSCS FD _ 3.1   8 /10 MSAF AD 9.50MIN _
190 33 3699 PRIMI 11/18/2013 38+2 153 65 28.8
GDM-
INS R 13 3
GDMIN
S
3.3,3.3,
3.3 3 39.45MIN LSCS FD _ 3.1  8 / 10 _ _ 39.45MIN _
191 22 300053 PRIMI 11/2/2013 40+3 148 40 18.2 _ R 13 3 PP
3,2.9,2.
9 3 57.30MIN LSCS PDECENT _ 3.3  8 / 10 _ _ 57.30MIN _
192 23 2117
G4P1L1A
2 11/14/2013 39+3 156 51 22.6 4
GDM-
INS R 8 4
GDMIN
S 2.2 1 6.50MIN NVD _ _ 2.7  8 / 10 _ _ 4.50MIN 2HRS
193 30 3866 PRIMI 11/11/2013 39 149 72 36
GDM-
INS R 9 2
GDMIN
S
3.2,3.1,
3.1 3 26HRS LSCS _ _ 3  8 / 10 _ _ 26HRS _
194 27 4732 PRIMI 11/5/2013 40 146 42 21.4 RH-VE R 8 4 RH-VE
2.9,2.8,
2.8 3 26HRS LSCS FD _ 2.9  8 / 10 MSAF AD 26HRS _
195 32 300553 PRIMI 11/15/2013 40 159 48 21.3 _ R 9.8 4 OD 2.3 1 14HRS VACUM _ _ 2.7  7 / 10 _ _ 11HRS 3HRS
196 26 9931
G4P1L1A
2 11/13/2013 40+3 147 45 21.75 2 _ R 8 3 PP 1.9 1 6.30MIN NVD _ _ 3.2  8 / 10 _ _ 5.50MIN 45MIN
197 35 8967 PRIMI 11/21/2013 38+4 140 51 26
GDM-
INS R 15 0
GDMIN
S 3.4 1 8HRS LSCS FD _ 3  8 / 10 _ _ 8HRS _
198 25 6983 PRIMI 11/7/2013 40+1 151 71 31.5 RH-VE R 11 2 RH-VE
2.9,2.9,
2.9 3 47.30MIN LSCS FINDUCTN _ 3.4   8 / 10 _ _ 47.30MIN _
199 27 8096 PRIMI 11/14/2013 39+3 145 53 27 _ R 4 1 PROM 3.2 1 7.20MIN LSCS FD _ 3.5  7 / 10 _ _ 7.20MIN _
200 22 3282 PRIMI 11/12/2012 40 158 50 22.2 _ R 8 3 OD 2.2 1 7.35MIN NVD _ _ 2.7  8 / 10 _ _ 6.20MIN 1.15MIN
201 24 8508 PRIMI 5/4/2012 40 145 52 26.5 _ R 9 0 OD 2.6,2.6 2 23.30MIN FORCEPS _ _ 2.2  7 / 10 _ _ 20.10MIN 3.20MIN
202 22 3460 G2P1L1 6/11/2012 40+1 160 58 22.6 4 _ R 9 0 PP
2.6,2.5,
2.5 3 28.7MIN NVD _ _ 2.7  7 / 10 _ _ 26.7MIN 2HRS
203 23 7357 PRIMI 11/25/2012 40+1 140 43 21.9 _ R 7.8 4 PP 2.6,2.4 2 15.50MIN NVD _ _ 2.7  8 / 10 _ _ 12HRS 3.50MIN
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204 30 50423 G2E1 11/24/2012 40+2 153 52 23.1 _ R 8 3 PP
3,2.9,2.
9 3 65.15MIN LSCS FD _ 3.3  8 / 10 _ _ 65.15MIN _
205 23 1317 PRIMI 12/21/2012 36 162 58 22.6
GDM-
INS R 17 4
GDMIN
S 2.6,2.5 2 12.50MIN NVD _ PPH 3.3  8 / 10 _ _ 11HRS 1.50MIN
206 25 9209 PRIMI 9/14/2012 40+2 149 47 23.9 _ R 9 0 PP 2.7 1 5.23MIN LSCS _ _ 3.5  8 / 10 _ _ 5.23MIN _
207 27 7681 G2P1L0 10/4/2012 37+4 143 52 26.5 _ R 3 4 OLIGO 2.7 1 6.35MIN LSCS FD _ 3.5  8 / 10 _ _ 6.35MIN _
208 32 4718 G2P1L1 7/12/2012 37+1 157 51 22.6 3
PRE-
ECL R 11 1
PRE_EC
L 3.2 1 4.45MIN LSCS FD TSYSTOLE 2.5  8 / 10 _ _ 4.45MIN _
209 30 9655 G2P1L1 8/2/2012 40+4 146 49 25 2 _ R 10 1 PP
3.5,3.4,
3.2 3 72HRS LSCS PROM _ 2.8  8 / 10 _ _ 72HRS _
210 30 8655 G2P1L1 8/22/2012 40 149 53 27 3 _ R 15 3 OD 1.7 1 7.20MIN NVD _ _ 3  7 / 10 _ _ 6HRS 1.20MIN
211 31 2824 PRIMI 9/4/2012 38+5 152 56 24.8 DM-INS R 12 3 DM-INS 2.7 1 8HRS LSCS FD _ 2.6  8 / 10 _ _ 8HRS _
212 29 5622
G3P1L1A
1 8/23/2012 40+2 159 55 24.4 3 _ R 12 1 PP 3.1,3 2 30.28MIN LSCS FD _ 3.5  8 / 10 _ _ 30.28MIN _
213 26 5366 PRIMI 6/12/2012 38+6 158 52 23.1 GDM-NS R 7.9 4
GDMIN
S 2.8,2.7 2 20.50MIN LSCS FD _ 3.6  8 / 10 _ _ 20.50MIN _
214 26 9993 G2P1L1 8/25/2012 40+2 154 51 22.6 4 _ R 7 3 PP 1.5 1 9HRS NVD _ _ 3  8 / 10 _ _ 8.15MIN 45MIN
215 28 9102 G2A1 9/6/2012 40+1 156 54 24 _ R 7 4 PP 2.7 1 46.30MIN LSCS FD _ 3.6  8 / 10 _ _ 46.30MIN _
216 29 8822 PRIMI 9/1/2012 40+2 162 68 26.5
GEST.H
T R 12 0
GEST.H
T
3.4,3.3,
3.3 3 32.17MIN LSCS FINDUCTN _ 2.8  8 / 10 _ _ 32.17MIN _
217 28 1177 PRIMI 23/10/2012 40+3 150 51 22.6 _ R 10 3 PP 3,3,3 3 25.4MIN LSCS MSL _ 3.2  7 / 10 MSAF AD 25.4MIN _
218 23 1719 G2P1L1 10/21/2012 39+5 159 53 23.5 3
PRE-
ECL R 7 4
PRE_EC
L 2.4,2.3 2 39.49MIN NVD _ _ 2.9  8 / 10 _ _ 38HRS 1.49MIN
219 24 8218 PRIMI 10/17/2012 40+2 152 55 24.4 _ R 6 2 PP 2.7,2.7 2 29.11MIN LSCS MSL _ 3.2   8 / 10 MSAF AD 29.11MIN _
220 26 1962 PRIMI 10/11/2012 40 156 119 52.8
PRE-
ECL R 8 3
PRE_EC
L 2.4 1 12.27MIN VACUM _ _ 3.4  7 / 10 _ _ 11HRS 1.27MIN
221 30 4168 G2P1L1 11/14/2012 40 153 52 23.1 6 _ R 11 4 OD 2.6 1 7.30MIN NVD _ _ 2.2  8 / 10 _ _ 6.30MIN 1HR
222 21 1315 PRIMI 11/6/2012 38+3 154 50 22.2 _ R 6 3 OLIGO 2.7 1 7HRS NVD _ _ 2.1  8 / 10 IUGR AD 6HRS 1HR
223 23 3743 PRIMI 10/10/2012 41+5 157 59 26.2 _ R 9 3 PP 2.5 1 19.10MIN NVD _ _ 2.9  8 / 10 _ _ 18HRS 1.10MIN
224 21 8604 PRIMI 10/26/2012 40 162 59 23 _ R 10 4 OD 2.3,2.3 2 14.10MIN NVD _ _ 3  8 / 10 _ _ 12HRS 2.10MIN
225 24 2533 G3P2L2 10/16/2012 40+3 151 55 24.4 4 _ R 11 3 PP 2.1 1 4.20MIN NVD _ _ 3.1   8 / 10 _ _ 3.30MIN 50MIN
226 34 5112
G4P1L1A
2 10/17/2012 40+2 158 49 21.7 7 _ R 9 2 PP 2.7 2 15.10MIN LSCS PDECENT _ 2.7  7 / 10 _ _ 12HRS 3.10MIN
227 22 1748
G4P2L2A
1 10/31/2012 40 156 57 25.3 5 _ R 8 3 OD
2.2,2.2,
2.1 3 33.20MIN NVD _ _ 2.6  8 / 10 _ _ 31.20MIN 2HRS
228 23 3173 PRIMI 11/18/2012 40+2 147 52 26.5 _ R 9 4 PP 1.6,1.6 2 26.38MIN NVD _ _ 2.8  8 / 10 _ _ 24.30MIN 2.8MIN
229 26 70429 PRIMI 11/21/2012 40+5 156 59 26.2 _ R 12 4 PP 2.1 1 7.37MIN LSCS MSL _ 3.1  8 / 10 _ _ 7.37MIN _
230 26 5996 PRIMI 11/23/2013 39+4 161 60 23.4 _ R 7 1 PROM 3.2 1 3.30MIN LSCS FD _ 3.2  8 / 10 _ _ 3.30MIN _
231 29 8030 PRIMI 11/21/2013 40 154 54 24 _ R 8 3 OD 2.3 1 13.15MIN FORCEPS _ _ 2.75  8 / 10 _ _ 10.15MIN 3HRS
232 25 7373 PRIMI 11/15/2013 40+1 150 54 24 _ R 15 2 PP
3.1,3.1,
3.1 3 72HRS LSCS FINDUCTN _ 3.3  8 / 10 _ _ 72HRS _
233 23 9651 G2P1L1 3/31/2012 40+1 153 51 22.6 2 _ R 4 1 OLIGO 3.2 1 7.30MIN LSCS FD _ 3  8 / 10 _ _ 7.30MIN _
234 33 9271 PRIMI 1/1/2013 40+1 159 50 22.2 _ R 9 2 PP 2.6,2.4 2 12HRS VACUM _ _ 3  8 / 10 _ _ 9HRS 3HRS
235 30 8559 G3P2L2 3/11/2013 40+1 160 56 21.8 3 _ R 9 3 PP 2 1 9.24MIN NVD _ _ 2.3  8 / 10 _ _ 8HRS 1.25MIN
236 26 1479 PRIMI 3/2/2013 40+1 162 69 26.9 _ R 8 1 PP 3.2 1 10.44MIN LSCS PROM _ 3.3  8 / 10 _ _ 10.44MIN _
237 31 4961 PRIMI 2/23/2013 40+2 158 64 28.4 _ R 9 1 PP 3.2,3.2 2 23.50MIN LSCS NPL _ 3.4  8 / 10 _ _ 23.50MIN _
238 25 3056 PRIMI 7/26/2013 40+4 159 52 23.1 _ R 6 4 PP 2.2,2 2 15.30MIN VACUM _ _ 3  8 / 10 _ _ 13HRS 2.30MIN
239 28 1209
G4P1L1A
2 12/5/2012 38+6 156 51 22.6 4
GDM-
INS R 9 4
GDMIN
S 2.3,2.2 2 14.55MIN NVD _ _ 2.4  8 / 10 _ _ 13.25MIN 1.30MIN
240 26 50954 PRIMI 3/18/2012 40+2 161 65 25.3 _ R 7 0 PP 3.4 1 9.15MIN LSCS FD _ 3.4  8 / 10 MSAF AD 9.15MIN _
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241 27 8128 PRIMI 11/8/2012 41+1 148 51 26 _ R 8 0 PP
3.4,3.3,
3.3 3 34.20MIN LSCS FINDUCTN _ 3  8 / 10 _ _ 34.20MIN _
242 27 2126 G2P1L1 11/7/2012 40+4 160 62 24.2 2 _ R 6 3 PP 2.4,2.4 2 20HRS NVD _ _ 2.7  8 / 10 _ _ 18HRS 2HRS
243 32 3193 G3A2 6/4/2012 40 152 49 21.7
GDM-
INS R 7 4
GDMIN
S 2.4 1 19HRS NVD _ _ 2.4  7 / 10 _ _ 17HRS 2HRS
244 29 8734 PRIMI 2/1/2012 40+3 155 65 28.8 _ R 6.3 2 PP 3.1 1 10.50MIN LSCS FD _ 2.5  8 / 10 MSAF AD 10.50MIN _
245 22 5992 PRIMI 2/2/2012 39+6 149 45 22.9 GDM-M R 6 2 GDM-M 2.3,2.2 2 20HRS NVD _ _ 2.6  8 / 10 _ _ 18HRS 2HRS
246 30 7818 PRIMI 1/25/2012 41+4 156 59 26.2 _ R 8 2 PP
3.2,3.2,
3.2 3 27.45MIN LSCS FD _ 2.8  8 / 10 TTN AD 27.45MIN _
247 25 6461 G2P1L1 1/30/2012 40+2 145 49 25 4 _ R 8.3 4 PP 1.9 1 13HRS NVD _ _ 2.7  8 / 10 _ _ 12HRS 1HR
248 27 2557 G2P1L1 12/12/2012 39+3 148 50 25 GDM-M R 8.2 3 GDM-M
2.5,2.4,
2.4 3 36.30MIN NVD _ _ 3.7  8 / 10 _ _ 34HRS 2.30HRS
249 29 1934 G2A1 12/15/2012 39 151 59 26.2
GDM-
INS R 12 0
GDM-
INS 3.2 1 13.15MIN LSCS FD _ 3  7 / 10 IDM AD 13.15MIN _
250 24 5640 PRIMI 12/5/2012 40+1 153 51 22.6 _ R 9.2 2 PP 3.1,3.1 2 25.40MIN LSCS MSL _ 3.7  8 / 10 MSAF AD 25.40MIN _
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